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Abstract 
 
 
 Bone is the second most implanted tissue next to blood causing approximately 2.2 million 
people to receive bone grafts each year.  Developing safe synthetic bone grafts allows quick and 
safe restoration of bone function while avoiding the surgical risks associated with bone 
autografting (self donation), and risks of disease transmission and immunogenic response 
associated with allografts (bone donated from other humans) and xenografts (grafts derived from 
animal tissue).  This dissertation entails the study and development of a novel potential synthetic 
bone graft consisting of a composite of calcium-deficient hydroxyapatite (CdHAP) biomimetically 
deposited in a bacterial cellulose (BC) hydrogel.   
To determine which conditions provided optimum cellulose growth from 
Gluconacetobacter hansenii (ATCC 10821), a statistical analysis of the effects of different culture 
parameters was carried out.  This utilized fractional factorial design which allowed a large number 
of factors to be tested using an abbreviated set of experiments.  Statistical software was also 
used to process the data to determine which factors and factor interactions were significant to 
bacterial cellulose production. 
Purified bacterial cellulose was mineralized by sequential incubations in solutions of 
calcium chloride followed by sodium phosphate dibasic.  This material was characterized using X-
Ray Diffractometry, Fourier Transform Infrared Spectroscopy, Scanning Electron Microscopy, 
Electron Dispersive Spectroscopy, and mechanical testing.  Characterization revealed that the 
CdHAP formed biomimetically in the BC in a manner similar to natural bone.  It was also 
determined that the CdHAP had comparable structure, size, and composition to that found in 
natural bone. 
An ideal bone replacement material will degrade after stimulating new osseous tissue 
production.  A chemical modification of the cellulose was carried out with periodate oxidation to 
render it degradable in-vivo.  The BC structure was preserved as well as its ability to mineralize 
 v
CdHAP after periodate oxidation.  This composite was characterized and its capacity to degrade 
was analyzed by subjecting the samples to a simulated aqueous physiological environment.   
The last chapter discusses how the BC-CdHAP composite may have clinical use in the 
major bone grafting procedures currently being administered.  Several surgeons were surveyed 
for this portion of the study to determine which grafts they used, the reasons for graft selection, 
and to obtain their opinion of the BC-CdHAP material.  It was ultimately determined that the BC-
CdHAP composite has ideal properties for dental bone grafting procedures including site 
extraction preservation and sinus lifts.   
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Chapter 1 
Introduction 
 
 
1.1.  Bone Biology 
 Bone is a specialized form of hard connective tissue that fulfills multiple functions 
including support, protection, blood production, and movement [1].  Bone is a composite material 
consisting of 25% water, 15% organic materials, and 60% mineral phases (by weight) [2].  The 
organic matrix consists of 95% Type I collagen with proteoglycans and noncollagenous proteins 
comprising the remaining 5% [3].  The main mineral component is calcium-deficient 
hydroxyapatite with traces of carbonate, fluoride, magnesium, chloride, and citrate ions [3]. 
 Bone consists of four types of cells: osteoblasts, osteocytes, osteoclasts, and bone lining 
cells.  Osteoblasts, osteoclasts, and bone lining cells exist on the bone surface while osteocytes 
are located within the bone tissue (Figure 1.1) [4].   
Osteoblast cells produce bone by creating a protein matrix layer called osteoid which is 
primarily collagen.  The osteoid is then mineralized by calcium and phosphorus salts precipitated 
from blood plasma as well as from direct apatite deposition from matrix vesicles [5].  As the 
 
 
 
Figure 1.1:  Topographic relationships among bone cells [4] 
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osteoblast becomes embedded within the mineralized osteoid, it matures into an osteocyte.  The 
osteocytes are regularly spaced throughout the mineralized matrix and are responsible for bone 
maintenance.  Osteocytes can also synthesize additional bone tissue and are capable of 
resorbing the bone matrix to a limited extent [3].  Bone lining cells are inactive flat osteoblasts that 
cover the surface of most bones.  Bone lining cells are believed to serve as a selective barrier 
between bone and the extracellular fluid compartments.  They may also regulate the movement 
of calcium and phosphate into and out of the bone [3]. 
Osteoblasts are derived from mesenchymal stem cells (MSCs).  MSCs are most 
commonly found in the bone marrow and the periosteum [6].  They have the capacity to 
differentiate into a variety of other cells which can produce cartilage, muscle, fat, ligament, and 
tendon (Figure 1.2) [6,7].  During differentiation, certain genes are turned on while others are 
turned off to produce specific structures and perform certain functions.  To differentiate into a 
mature osteoblast, MSCs must undergo several transitional steps via intricate pathways (Figure 
1.3) which are regulated by a series of signaling factors [7].  Bone morphogenetic protein-2 
(BMP-2) is a bone signaling factor which has been extensively studied [8,9].  Along with 
regulating bone development and osteogenesis, BMP-2 is also osteoinductive.  This growth factor 
has the ability to convert undifferentiated mesenchymal cells into osteoblasts and chondrocytes 
[10].  A recent strategy of bone grafting is the incorporation of BMP-2 to induce mesenchymal cell 
proliferation, subsequent osteoblast differentiation, and new bone formation [10].   
Other protein growth factors have been proven to affect bone growth including 
transforming growth factor β (TGF-β), platelet derived growth factor (PDGF), and insulin-like 
growth factor (IGF).  Along with signaling factors, bone growth is also regulated by hormones 
such as calcitonin, vitamin D, and parathyroid hormone.  Mechanical loading is also an important 
stimulus for bone growth as is dictated by Wolff’s Law.  
Osteoclasts are multinucleated cells that resorb old or worn bone to be subsequently 
replaced by new bone [3].  Unlike osteoblasts which are derived from MSCs, osteoclasts originate 
from the fusion of mononuclear precursors [4].  During bone remodeling, osteoclasts degrade the  
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 Figure 1.2: Mesenchymal stem cell lineages and resulting tissues [6] 
 
 
 
Figure 1.3:  Schematic of signaling factor network that controls mesenchymal cell differentiation 
into osteoblasts and chondrocytes [7] 
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matrix which is replaced by new bone matrix produced by the osteoblasts [7]. 
Bone development is either classified as intramembranous or endochondral [3].  
Intramembranous ossification entails the direct replacement of connective tissue with bony tissue. 
After connective tissue formation, osteoblasts migrate into the matrix and deposit osseous tissue.  
This occurs in the formation of the cranial vault, facial skeleton, parts of the mandible, and the 
clavicle.  During endochondral bone formation, hyaline cartilage is replaced with bony tissue.  The 
hyaline cartilage becomes infiltrated with blood vessels and osteoblasts to become the 
periosteum.  The osteoblasts then deposit bone as the cartilage disintegrates.  Weight bearing 
bones, bones that terminate in joints, most of the cranial base, and a portion of the mandible are 
formed via endocondral ossification [3]. 
Bone is classified as either cortical or cancellous.  Cortical (or compact) bone is dense 
and primarily found in the shaft of long bones (the diaphysis).  It also forms an outer shell at the 
ends of long bones (epiphysis) and also around vertebrae.  The basic structure of cortical bone is 
called a Haversian System or osteon.  In the osteon, the osteocytes are arranged in concentric 
circles (lamellae) around the central Haversian Canal which contain blood vessels and nerves 
(Figure 1.4).  Volkmann’s Canals are perpendicular tubular passages that link the blood vessels  
 
 
Figure 1.4:  Structure of cortical and cancellous bone [Image taken from http://en.wikipedia.org] 
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of one Haversian System to another.  Nutrients and metabolites from the Haversian Canal are 
unable to permeate the mineralized osteoid to the embedded osteocytes.  To access these 
solutes and maintain communication with other cells, osteocytes rely on surrounding extracellular 
spaces (lacunae) and interconnecting cytoplasmic projections (canaliculi) [3].   
Cancellous (or trabecular) bone is spongy and less dense than cortical bone.  Cancellous 
bone is found at the ends of long bones (the epiphysis) as well as in vertebrae.  It consists of 
trabeculae and bars of bone which are surrounded by the vascularized red marrow bed.  In 
cancellous bone, the canaliculi connect to the osteocyte to the marrow bed to access the blood 
supply as opposed to a central Haversian Canal [3]. 
 
1.2.  Bone Grafting 
Bone is the second most implanted tissue next to blood.  Bone grafts are used to repair 
defects caused by surgery, trauma, tumors, disease, congenital deformities, as well as implant 
revisions and infections [11].  Bone grafts are also used for spinal fusion and to strengthen the 
bone prior to orthopaedic and dental implantation [11,12].  Each year, approximately 450,000 
bone graft procedures are performed in the U.S. with 2.2 million procedures conducted worldwide 
[13].  A market survey performed by Kalorama Information (Rockville, MD, U.S.A.) estimates that 
the global market for bone grafts in 2004 was approximately $1 billion and is projected to 
approach $4.5 billion by 2012 [14].  A similar survey conducted for the European market found 
that orthopaedic biomaterial sales were ~$1.1 billion in 2005 and should reach $5.0 billion in the 
year 2010 [15].  The primary drivers for this growth are increasing numbers of spinal fusion and 
revision joint replacement surgeries, as well as the aging population and inflationary price 
increases [14]. 
A bone graft stimulates new bone growth by three mechanisms: osteoconduction, 
osteoinduction, and osteogenesis [12,16,17].  In osteoconduction, the graft serves as a scaffold 
to support bone ingrowth and/or deposition [12,17].  Osteoconduction can only occur in bony sites 
since it relies on preexisting bone cells or mesenchymal cells [12,17].  Osteoinductive materials 
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can promote bone growth in soft tissues outside of the bony skeleton because they contain 
growth factors (e.g. BMP-2) that stimulate non-differentiated mesenchymal cells to become bone 
cells [12,16,17].  Osteogenic materials contain living cells (e.g. stem cells, osteoprogenitor cells) 
that are capable of differentiating and facilitating the bone formation process [16]. 
Bone grafts can be categorized into four main types: autografts (self-donated bone), 
allografts (donated from another human), xenografts (donated from another species), and 
alloplasts (synthetic bone grafts).  The advantages and disadvantages of each technique will be 
discussed in the following sections. 
 
1.2.1.  Autografts 
 Termed the “gold standard” of bone grafts, autogenous bone exhibits all three 
mechanisms of bone healing: osteoconduction, osteoinduction, and osteogenesis.  Currently, it is 
the only osteogenic material available.  Autogenous bone grafts are histocompatible, do not 
transfer disease, and retain viable osteoblasts that produce new bone [18].   
Autogenous grafts can be obtained in cancellous form, nonvascularized or vascularized 
cortical form, or a combination of the three [18].  Cancellous bone has a suitable 
hydroxyapatite/collagen framework for osteoconduction and possesses osteogenic cells [18].  
Denser cortical bone is less suitable for osteoconduction, and does not possess osteogenic cells.  
However, cortical bone has superior compressive strength and a larger concentration of BMP that 
can stimulate osteogenesis from neighboring cells [12,17,18].  Cortical bone also provides a 
suitable barrier against soft tissue ingrowth [12,17].  Vascularized grafts prevent cell necrosis and 
improve viability [18].  However, vascularized grafts increase the chance of donor-site morbidity 
and prolong operation time [18].  While vascularized grafts are initially biomechanically superior to 
non-vascularized grafts, there is no significant difference between the two after six months [18].   
 Autogenous bone can be obtained from several areas.  In selecting the donor site; the 
location of the recipient bed, the quality and quantity of bone required, and potential 
complications are considered [19].  For maxillofacial procedures, intraoral sources can be used 
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including the mandibular symphysis, maxillary tuberosity, ramus, and exostoses [12].  Ribs have 
also been used to reconstruct the mandible [17].  While a significant amount of cancellous bone 
can be obtained from the proximal tibia [20], the iliac crest offers the greatest amount of usable 
cortical and cancellous bone.  The iliac crest is also easy to access making it the most common 
donor site for bone autografting [19]. 
 The iliac can be accessed either anteriorly or posteriorly.  In a typical anterior iliac bone 
graft harvesting procedure, a 3-6 cm incision is made parallel to the anterior iliac crest starting 
from at least 2 cm superolaterally from the anterior superior iliac spine (Figure 1.5) [21].  Posterior 
bone grafts require an almost vertical incision over and slightly lateral to the posterior iliac spine 
and parallel to route of the superior cluneal nerves [19].  After the skin is retracted, the dissection 
proceeds through the fascia to the superior border of the iliac [21].  The periosteum is dissected 
and the graft is cut with a bone saw (Figure 1.5) [21].  On average, 10-15 cm3 of bone is 
harvested from the iliac during this procedure, though up to 55 cm3 of bone can be obtained from 
this site [19]. 
While autografts are osteoconductive, osteoinductive, osteogenic, and do not elicit an 
immunogenic response; there are many shortcomings and potential complications associated 
 
  
 
Figure 1.5:  Photograph showing position and extent of incision required for anterior iliac crest 
(left).  Operative photograph showing bone harvesting from ilium using a single-bladed oscillating 
bone saw (right) [21] 
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with this procedure.  The most common drawbacks are associated with the second operation 
which can produce pain, infections, hematomas, donor site morbidity, prolonged anesthesia time, 
significantly increased operative blood loss, and a longer hospital stay [18-22].  A high rate of 
repeat operative interventions is associated with these postoperative problems [20].  Gazdag et 
al. report that the rate of donor site morbidity for the iliac crest is as high as 25% [18].  Patients 
have also reported having sensory disturbances associated with nerve damage, having 
complaints about cosmetic appearance, and experiencing functional disability [19].  Joshi and 
Kostakis performed a post-operative investigation of patients who underwent iliac crest graft 
harvesting and found that 14% of the patients surveyed experienced gait disturbance, and 22% 
required use of a walking stick or wheelchair from 0.5 to 26 weeks postoperatively [22].  While 
overall rates of patient complications vary between studies, reports range from 2.8% to as high as 
49% [20,21].  Additionally, failure occurs in 15-25% of autogenous cortical transplants due to 
inadequate fixation and improper biological, physiological, and mechanical properties [23]. 
The amount of bone that can be obtained from autografting procedures is limited, 
especially in elderly patients [23].  Certain procedures, such as bone tumor surgery and joint 
implant revision, often require large quantities of bone which cannot be obtained in sufficient 
quantity and quality from the host without significant risk [23]. 
 
1.2.2.  Allografts 
 Allograft bone is obtained from other individuals of the same species but with different 
genotypes.  Bone allografts can be obtained from cadavers as well as living persons [11,12].  
Allografts are processed into a variety of forms including fresh-frozen, irradiated, freeze-dried, 
and demineralized freeze-dried bone.   
While fresh-frozen bone is osteoconductive, there is a significant risk of disease 
transmission and host-graft rejection associated with this graft.  For this reason, it is not used in 
certain clinical applications including implant dentistry [11].   
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Irradiated bone is subjected to 6-8 million rads of radiation to decrease the risk of disease 
transmission [12].  It has been claimed that irradiated bone provides a response closest to that 
achieved with autogenous bone compared with other bone grafts [12].  However, it is not widely 
used due to continuing concerns about disease transmission [17].   
Over 95% of bone allografts are freeze-dried [24].  This action causes osteoblasts to 
release BMPs and bestow osteoinductivity.  However, freeze-dried bone is reported to have an 
unpredictable performance once implanted.   
Demineralized freeze-dried bone (DFDB) is subjected to hydrochloric or nitric acid for 6-
16 h which removes the calcium and phosphate salts from the bone matrix.  This releases BMPs 
giving the graft osteoinductive potential, however it has been contested whether there are 
sufficient amounts of BMPs in DFDB to stimulate osteoinduction [17].  Other studies did not find a 
significant difference between the performance of DFDB and freeze-dried bone allograft [12].   
Allografts are readily available and their use eliminates the complications associated with 
the second operation required with autografting [12].  Allogenic bone grafts are increasingly being 
used in orthopaedic reconstruction surgery [24].  Several commercialized bone graft products 
based on allograft bone or demineralized bone are currently on the market (Table 1.1).   
Significant complications may occur with bone allografts.  The chief disadvantage is the 
elicitation of an immunological response that can result in graft rejection [23].  Antigens present in 
the allograft can cause both humoral and cellular mediated rejection [14].  Graft rejection can 
cause disruption of blood vessels and an inflammatory reaction that includes lymphocyte 
infiltration, fibrous encapsulation, peripheral graft resorption, callus bridging, nonunions, and 
fractures [23].  Allograft remodeling requires a significant amount of time and could also result in 
a late rejection [23].  Bone allografts can also transmit a multitude of diseases and viruses 
including hepatitis B and C as well as human immunodeficiency virus [24].   
While many of the aforementioned processes (freeze-drying, demineralization, 
irradiation) are employed to destroy antigens, these methods can mechanically weaken and 
chemically alter the graft.  This can render the allograft unsuitable for successful bone 
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Table 1.1:  FDA approved bone allograft products  
 
Graft Name Manufacturer Material Description 
Accell® IsoTis OrthoBiologics: 
Laussanne, Switzerland 
Putty consisting of demineralized bone matrix 
(DBM) in a polymer (pluronic) carrier  
Dynagraft® II IsoTis OrthoBiologics: 
Laussanne, Switzerland 
DBM in a sodium hyaluronate carrier 
Orthoblast®II IsoTis OrthoBiologics: 
Laussanne, Switzerland 
DBM in a polymer (pluronic) carrier 
Allomatrix® 
Custom 
Wright Medical: Arlington, 
TN, U.S.A. 
Putty with DBM, allograft cancellous bone 
chips, and calcium sulfate  
Allomatrix® Putty  Wright Medical: Arlington, 
TN, U.S.A. 
DBM with a binding medium of calcium sulfate 
and carboxymethylcellulose 
Osteoset® 2 
DBM 
Wright Medical: Arlington, 
TN, U.S.A. 
DBM in calcium sulfate pellets 
DBX® 
Demineralized 
Bone 
Musculoskeletal 
Transplant Foundation: 
Edison, NJ, U.S.A. 
DBM in a sodium hyaluronate carrier 
Grafton® Osteotech: Eatontown, NJ, 
U.S.A. 
DBM in a starch carrier 
Intergro™ Interpore Cross 
International: Irvine, CA, 
U.S.A. 
DBM with coral-derived hydroxyapatite in a 
lecithin carrier 
Opteform®, 
Optefil® 
Exactech Inc: Gainesville, 
FL, U.S.A. 
DBM, cortical and cancellous bone chips in a 
gelatin carrier 
Optium DBM® LifeNet: Virginia Beach, 
VA, U.S.A. 
DBM combined with glycerol/glycerin 
  
substitution, and none of these techniques can ensure complete removal of antigenicity [23].  
 In a study of patients who received allogenic bone, a 75-85% success rate was reported.  
However, only 50% of the patients had an entirely uncomplicated postoperative course.  One 
quarter of the patients required further surgery such as autologous grafting, replating for stress 
fractions, or delayed union.  Worst-case scenarios included graft excision due to infection, 
reimplantation, long term bracing, and amputation [24].   
 
1.2.3.  Xenografts 
Bone xenografts are obtained from another species, most commonly bovine [17].  
Several bone xenograft products either use entire bovine bone, hydroxyapatite isolated from 
bovine bone, or isolated bovine collagen in combination with other growth factors or ceramic 
particles.  Another product called Bioset XC™ (Regeneration Technologies, Inc.: Alachua, FL, 
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U.S.A.) consists of bovine bone and human demineralized bone in a porcine gelatin carrier.  
Examples of other xenograft bone substitutes currently on the market are given in Table 1.2. 
Many studies have reported the success of bone xenografts.  For example, BioOss® 
(Osteohealth: Shirley, NY, U.S.A.) has had favorable results as a dental bone graft specifically in 
guided tissue regeneration around titanium implants [25,26].  While xenografts are extensively 
processed and sterilized to prevent immunogenic response, risks of disease transmission and 
adverse reactions can still occur.  Additional investigations have shown poor performance of 
xenografts in other bone grafting procedures [27-30].  In a study of eleven patients who received 
bovine bone grafts for spinal fusion, Schutlheiss et al. found that only two patients had complete 
osseointegration and only three had partial osseointegration [27].  Xie et al. found that bovine 
bone incited fibrous tissue growth when used in spinal fusion which was attributed to low 
biocompatibility [28].  Charalambides et al. investigated the use of xenografts for hip revision 
 
Table 1.2:  FDA approved bone xenograft products 
 
Graft Name Manufacturer Material Description 
Sterling® 
Cancellous 
Chips and Cubes  
Regeneration Technologies, 
Inc.: Alachua, FL, U.S.A. 
Bovine bone 
Bioset XC™ Regeneration Technologies, 
Inc.: Alachua, FL, U.S.A. 
Bovine bone, human demineralized bone 
matrix, porcine gelatin 
BioOss® Osteohealth: Shirley, NY, 
U.S.A. 
Bovine-derived hydroxyapatite 
Osteograf® Dentsply: Lakewood, CO, 
U.S.A. 
Bovine-derived hydroxyapatite 
PepGen P-15® Dentsply: Lakewood, CO, 
U.S.A. 
Bovine-derived hydroxyapatite enhanced with 
a synthetic peptide that mimics the cell-
binding domain of Type-I collagen 
Healos® DePuy Spine: Raynham, 
MA, U.S.A. 
Cross-linked bovine collagen fibers fully 
coated with hydroxyapatite 
Collagraft® Zimmer: Warsaw, IN, U.S.A. Purified fibrillar bovine collagen with 
hydroxyapatite and tricalcium phosphate 
granules 
CopiOs™ Zimmer: Warsaw, IN, U.S.A. Calcium phosphate dibasic in bovine collagen 
Vitoss® Orthovita: Malvern, PA, 
U.S.A. 
80% β-tricalcium phosphate, 20% bovine 
collagen  
Infuse® Medtronic: Minneapolis, 
MN, U.S.A. 
Bovine collagen sponge with recombinant 
human bone morphogenetic protein-2  
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surgery and found a significant loss of bone incorporation and also reports of infection and 
rejection [29].  Another study used xenografts to repair tibial osteotomies and reported a 
significant number infections and absence of cell infiltration [30].  The extensive processing that 
animal bone must undergo to become safe grafts also causes xenografts to lose mechanical and 
structural integrity [31].   
 
1.3.  Alloplasts 
 Alloplasts are synthetic materials used for tissue substitution.  Since they are readily 
available, they eliminate the complications associated with the second operation required of 
autografts.  By utilizing biocompatible and hypoallergenic materials, alloplasts are devoid of the 
risks of disease transmission and immunogenic response related to allografts and xenografts.  
Alloplasts can also be economically produced in a variety of shapes of sizes and can be modified 
to host specific physical and chemical properties.  Most alloplasts are composed of ceramics, 
polymers, or ceramic-polymer composites.  These specific alloplasts will be discussed further in 
the following sections.  Metals are also being investigated for bone substitution.  A new metal 
bone graft called Trabecular Metal™ consisting of elemental tantalum is currently manufactured 
by Zimmer (Warsaw, IN, U.S.A.).  Titanium is also widely used to repair severe fractures and 
reconstruct joints due to its unique ability to osseointegrate, or bond with bone [32].   
 
1.3.1.  Ceramic Bone Grafts 
 Most commercially available bone alloplasts are ceramic based (Table 1.3).  Each of 
these materials exhibit osteoconduction by providing a scaffold for bone in-growth [12,33]. 
Calcium sulfate (Ca2SO4) was first reported to fill bony defects in 1892 by Dressmann 
[33].  Calcium sulfate is an inexpensive material often mixed with water to form a dense paste 
and used to fill the defect [17].  There are reports that antibiotic laden Ca2SO4 paste can 
successfully be used in the presence of infection [33].   
A major complication of Ca2SO4 paste is the exothermic setting process which can  
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Table 1.3:  FDA approved ceramic based bone alloplast products  
 
Graft Name Manufacturer Material Description 
Osteoset® Wright Medical: Arlington, TN, 
U.S.A. 
Calcium sulfate pellets 
Stimulan® Biocomposites Limited: 
Staffordshire, U.K. 
Calcium sulfate pellets 
NovaBone®, 
PerioGlas® 
Novabone: Jacksonville, FL, U.S.A. Bioactive glass comprised of silica 
and calcium 
Allogran-R® 
 
Biocomposites Limited: 
Staffordshire, U.K. 
Porous β-tricalcium phosphate 
granules  
GenerOs™ Berkeley Advanced Biomaterials 
Inc: Berkeley, CA, U.S.A. 
Porous β-tricalcium phosphate 
granules 
 
chronOS™ Synthes: West Chester, PA, U.S.A. Porous β-tricalcium phosphate 
Conduit™ DePuy Spine: Raynham, MA, 
U.S.A. 
Porous β-tricalcium phosphate 
granules 
Bioresorb® Oraltronics: Bremen, DE Micro and macroporous β-tricalcium 
phosphate 
Cellplex® Wright Medical: Arlington, TN, 
U.S.A. 
β-tricalcium phosphate granules 
TheriGraft™, 
TheriLok™, 
Theriwedge™, 
Therilink™ 
Therics: Akron, OH, U.S.A. β-tricalcium phosphate in various 
forms (putty, granules, wedge, slab)  
BoneSave™ Stryker: Kalamazoo, MI, U.S.A. 80% β-tricalcium phosphate, 20% 
hydroxyapatite granules 
Genex® Biocomposites Limited: 
Staffordshire, U.K. 
Porous hydroxyapatite and β-
tricalcium phosphate particles with a 
negative charge 
Bi-Ostetic™ Berkeley Advanced Biomaterials 
Inc: Berkeley, CA, U.S.A. 
60% hydroxyapatite, 40% β-tricalcium 
phosphate 
MasterGraft™ Medtronic Sofamor Danek: 
Memphis, TN, U.S.A. 
60% hydroxyapatite, 40% β-tricalcium 
phosphate 
Cem-Ostetic™ Berkeley Advanced Biomaterials 
Inc: Berkeley, CA, U.S.A. 
Nanocrystalline hydroxyapatite and β-
tricalcium phosphate in a neutral pH 
bone putty that sets after application 
Pro Osteon™ Interpore Cross International: Irvine, 
CA, U.S.A. 
Porous hydroxyapatite derived from 
marine coral 
Allogran-L® 
 
Biocomposites Limited: 
Staffordshire, U.K. 
Multiporous hydroxyapatite granules  
Calcitite® Zimmer Dental: Carlsbad, CA, 
U.S.A. 
Sintered hydroxyapatite particles 
Osteogen® Impladent Ltd.: Holliswood, NY, 
U.S.A. 
Resorbable synthetic hydroxyapatite  
Norian SRS® Synthes: West Chester, PA, U.S.A. Carbonated apatite cement 
α-BSM® Johnson and Johnson: Piscataway, 
NJ, U.S.A. 
Calcium phosphate paste that forms 
poorly crystalline hydroxyapatite after 
application 
BoneSource®, 
HydroSet™ 
Stryker: Kalamazoo, MI, U.S.A. Calcium phosphate cement that 
converts to hydroxyapatite after 
application 
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damage bone [17].  Utilizing calcium sulfate pellets like those in Osteoset® and Stimulan® (Table 
1.3) alleviates problems associated with setting.  However, Ca2SO4 dissolves quickly and the 
resorption profile has been reported as unpredictable [17].  Further concern has been raised 
regarding the release of sulfur into the body [17].  For these reasons, it is not widely used as a 
bone graft [17].   
Bioactive glass is an amorphous material made from calcium, phosphate, sodium, and 
silicon salts [12].  This material is found in the commercial products NovaBone® and PerioGlas® 
(Table 1.3).  Bioactive glasses permit a surface modification after implantation which allows 
bonding to soft and hard tissues [2].  However, certain studies have reported rapid dissolution of 
and breakdown of bioactive glass during oral implantation [12].  The production costs of bioactive 
glass are also significantly high [34]. 
As the mineral phase of bone is principally calcium phosphate, calcium phosphate 
ceramics are a common synthetic bone substitute, and have been used in medicine and dentistry 
for nearly 30 years [2].  The three most commonly used calcium phosphates in bone alloplasts 
consist of β- tricalcium phosphate (β-TCP), hydroxyapatite (HAP), and biphasic calcium 
phosphate (BCP) which is a mixture of β-TCP and HAP. 
β-tricalcium phosphate (β-TCP) is biocompatible, is resorbable by osteoclasts, and can 
be replaced by new bone [17].  While it is chemically similar to hydroxyapatite, it is not a natural 
component of bone mineral [12].  β-TCP rapidly dissolves in approximately six weeks after 
implantation which makes it inappropriate for use in some applications [33].  It is also reported 
that its resorption rate is variable and dependent on the implant site as well as the material’s 
structure, porosity, and chemistry.  The chemical structure and properties of β-TCP may also be 
altered after heat sterilization [12]. 
β-TCP is not as widely used as hydroxyapatite (HAP), which is the preferred calcium 
phosphate alloplast [17].  Hydroxyapatite resembles the principal inorganic component of bone 
[2,12,17] and is found in several synthetic bone alloplasts (Table 1.3).  Synthetic hydroxyapatite is 
biocompatible and readily bonds to hard and soft tissues [12].   
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Commercial production of HAP entails conversion from other calcium compounds or by 
aqueous precipitation (combination of a calcium salt and an alkaline phosphate or a reaction 
between calcium hydroxide or calcium carbonate and phosphoric acid) [2].  HAP can also be 
produced via solid-state processing, hydrolysis, and hydrothermal synthesis.  The physical and 
chemical properties of HAP are dependent on its route of synthesis [2].  These properties directly 
affect its biological response, rate of resorption, and appropriate clinical application [12].   
The stoichiometry of HAP is highly dependent on its processing conditions and greatly 
affects its biological properties.  Stoichiometric hydroxyapatite (sHAP) is represented by the 
compound Ca10(PO4)6(OH)2.  Fully calcium-deficient hydroxyapatite (CdHAP) takes on the form 
Ca9(HPO4)(PO4)5(OH).  Physiological HAP is almost always calcium deficient compared to 
stoichiometric hydroxyapatite due to contact with a constant flow of trace ions.  Physiological 
apatite can take on the form Ca10-x(HPO4)x(PO4)6-x(OH)2-x with 0< x ≤ 1 [35].  
CdHAP is more favorable as a bone implant compared to sHAP because it dissolves 
faster in aqueous environments [36,37].  CdHAP quickly forms a biomimetic layer of apatite on its 
surface which enables rapid bonding with bone [38].  The stability and resistance to dissolution 
prevents sHAP from permitting this surface modification [39].  This is confirmed by an in-vivo 
study, conducted by Bourgeois et al., which demonstrated that CdHAP induced rapid bone 
colonization with nearly complete degradation after two weeks while sHAP generated much less 
bone formation [37].  CdHAP also has a large specific surface area, which facilitates the loading 
of therapeutic agents that may further increase bone cell colonization [37].  As most synthetic 
HAP is processed and sintered at high temperatures, it assumes a stoichiometric form.   
The hydroxyl groups of hydroxyapatite can undergo ionic substitution which affects its 
properties.  Incorporation of carbonate ions has been shown to increase apatite dissolution and 
may increase the bone replacement process after implantation [40].  Apatites that contain fluoride 
ions are more likely to retard demineralization and dissolution [41]. 
Processing conditions also affect the physical form of HAP including particle size, 
porosity, and crystallinity [12].  Larger crystallites take a long time to resorb while small particles 
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dissolve more quickly.  High crystallinity also imparts longer resorption time.  Dense HAP blocks 
are brittle, but have high compressive strength.  It is widely accepted that materials with 150-200 
μm pores are necessary for optimal bone ingrowth and angiogenensis, but higher porosity 
decreases strength [12].   
 
1.3.2.  Ceramic-Polymer Composite Bone Grafts 
 While pure ceramic alloplasts possess strength, fatigue resistance, and bioactivity; they 
are much more brittle than natural bone.  High stiffness causes ceramic alloplasts to weaken 
under tensile or shear loading, limiting their applications to either coatings or low weight bearing 
applications [42].  One method to improve the mechanical properties of ceramic bone grafts is to 
combine them with a polymer into a composite.  By distributing a discontinuous phase of ceramic 
particles within a continuous polymer matrix, the polymer reduces the elastic modulus and 
becomes reinforced by the strength of the ceramic particles [42].   
This mimics the composition of natural bone.  Bone is a well-established natural 
composite whose structure enables the functional demands of locomotion, protection, support of 
an upright stance [43].  The composite structure of bone permits an effective transfer of stress 
between the matrix phase (collagen) and the reinforcing phase (CdHAP nanocrystallites) [43].   
A few ceramic-polymer bone grafts are currently in clinical use (Table 1.4).  Another 
ceramic-polymer bone graft called Cortoss® (Orthovita: Malvern, PA, U.S.A.) is in commercial use 
in Europe.  Cortoss® consists of bioactive glass, barium boro-aluminosilicate glass, and 
amorphous silica particles suspended in a methacrylate matrix consisting of bisphenol-a-glycidyl 
dimethacrylate, bisphenol-a-ethoxy dimethacrylate, triethylene glycol dimethacrylate.  It does not 
have FDA approval for use in the U.S.A., and is currently undergoing clinical trials. 
A criticism to using methacrylate based polymers like those in Cortoss® and Bioplant® is 
that they are non-degradable [17].  Additionally, these polymers release a significant amount of 
heat during polymerization (e.g. setting).  There are also concerns in using polylactic acid and  
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Table 1.4:  FDA approved ceramic-polymer composite bone alloplast products 
Graft Name Manufacturer Material Description 
Bioplant® Sybron Dental Specialties: 
Newport Beach, CA, U.S.A. 
Copolymer of polymethylmethacrylate 
(PMMA) and polyhydroxyethylmethacrylate 
(PHEMA) with layers of barium sulfate and 
calcium hydroxide 
Biogran® 3i: Palm Beach Gardens, 
FL, U.S.A. 
Silica gel surrounded by a calcium phosphate 
shell 
BIORCI™-HA Smith and Nephew 
Endoscopy: Andover, MA, 
U.S.A. 
Screw consisting of polylactic acid (PLA) and 
hydroxyapatite 
COLLAXO™ 
 
Smith and Nephew 
Endoscopy: Andover, MA, 
U.S.A. 
Screw consisting of poly(DL lactide-co-
glycolide) and calcium carbonate 
 
poly(DL lactide-co-glycolide) polyesters which are found in BIORCI™-HA and COLLAXO™.   
While these polymers are absorbable, they release a massive amount of acidic products (e.g. 
lactic and glycolic acid) as they degrade [44].  These products significantly accumulate beyond 
clearing rate when these polymers are used in orthopaedic applications, increasing the probability 
of a serious inflammatory response [44]. 
 
1.4.  Bacterial Cellulose 
 Cellulose is a polysaccharide consisting of β-(1,4) glucan sugars connected by glycosidic 
linkages (Figure 1.6).  As the primary component of plant cell walls, cellulose is the most 
abundant natural polymer in the world with an estimated 1010-1011 tons produced each year [45].   
Certain bacterial species, namely Gluconacetobacter spp., possess the ability to secrete pure 
cellulose in the form of a hydrogel [46].  Though identical in chemical composition, the structure 
and physical properties of plant and bacterial cellulose differ greatly.  
The main function of plant cellulose is to provide structure for the vegetable fibers.  Plant 
cellulose is generally associated with other biopolymers such as hemicellulose and lignin to form a 
laminate.  Extracting cellulose requires harsh chemical processes, such as treatment with sulfur dioxide, 
sodium hydroxide, and bleaching agents.  This often causes the cellulose to lose strength.   
Produced in a pure form, bacterial cellulose (BC) does not have to be isolated with 
extensive chemical treatment.  The bacteria naturally synthesize the cellulose into a crystalline 
 Figure 1.6:  Chemical structure of cellulose chain 
 
three-dimensional network.  Gluconacetobacter spp. extrude cellulose subfibrils with a ~1.5 nm 
width which crystallize into nanofibrils that in turn bond together to form ribbons that are typically 
3-4 nm thick, 70-80 nm wide, and 1-9 μm long.  The ribbons twist and overlap to form parallel 
crystal lattice planes which stack on top of each other to form the thickness of the pellicle, a gel-
like membrane [46].  Cellulose has an abundance of hydroxyl groups which permits extensive 
hydrogen bonding.  As BC fibrils are up to 200 times finer than plant cellulose fibrils, it contains a 
higher density of inter- and intrafibrillar hydrogen bonds which gives the cellulose its network 
structure [47].  Nishiyama et al. performed a thorough structural analysis of cellulose Iα which is 
the main crystal component of bacterial cellulose [48].  Their results conclude that cellulose Iα has 
two alternative hydrogen bonding networks (Figure 1.7). 
Hydrogen bonding enables the BC to hold water in its interstitial spaces allowing 
immense water retention [49].  Water makes up 99.8% of the total volume of the matrix with pure 
cellulose comprising the remaining 0.2% [50].  Hydrogen bonding also grants the cellulose high 
strength.  Nishi et al. claimed that dried BC has the highest Young’s Modulus (15-30 GPa) ever 
known in two-dimensional organic materials [49]. 
Though BC has been used as a food source (“nata-de-coco”) in the Philippines for many 
years, additional uses for this biopolymer have emerged.  Due to its high strength, dried BC is 
used in acoustic diaphragms for speakers and headphones (Sony Corporation: Tokyo, Japan).  
Modified bacterial cellulose and BC composites have been developed for fuel cell applications 
[51], while other composites are being investigated for electronic materials [52,53]. 
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Figure 1.7:  Two alternative hydrogen-bonding patterns of cellulose Iα as determined by 
Nishiyama et al. [adapted from reference 48] 
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1.4.1.  Bacterial Cellulose in Medicine 
Plant cellulose has been an established biomaterial for many years.  It is a biocompatible 
polymer employed in the production of dialysis membranes, drug coatings, and blood coagulants, 
and many other products [54]. 
 With the benchmark of plant cellulose, BC is currently being investigated for a variety of 
medical applications including tissue substitution.  A tissue substitute should mimic the structure 
of natural extracellular matrices and be composed of biocompatible materials conducive to 
appropriate cell attachment and proliferation [55].  Collagen is the most ubiquitous extracellular 
matrix component and is found in almost every type of tissue including skin, ligament, muscle, 
cartilage, and bone.  All of these tissues are composed of collagen fibrils which range in diameter 
from 50-500 nm [56].  The nanofibril matrix of bacterial cellulose mimics the structure and scale of 
collagen fibrils indicating its great potential for use as a biomaterial [57]. 
The BC hydrogel is also very hydrated and porous like living tissue.  Hydrogels allow the 
permeation of water, metabolic products, and chemical signals in the aqueous physiological 
environment [58].  Because 99.8% of the cellulose mass is water, and the 0.2% cellulose that is 
present is an inert polysaccharide, bacterial cellulose is relatively pure.   
 Watanabe et al. found that modified bacterial cellulose was comparable to tissue culture 
dish as a substrate for mammalian cell adhesion [59].  Paul Gatenholm’s group have studied the 
use of bacterial cellulose as a tissue engineering scaffold for cartilage and blood vessels [57,60].  
It was found that chondrocytes grew better on unmodified bacterial cellulose compared to tissue 
culture dish and calcium alginate [60].  The mechanical properties of BC were determined to be 
similar to that of the carotid artery and smooth muscle cells were able to adhere, proliferate, and 
migrate into the BC scaffold [57].  Additionally, the candidate’s master’s thesis work showed that 
osteoblasts adhered and proliferated on bacterial cellulose indicating its potential for bone 
substitution [61]. 
 The in-vivo biocompatibility of bacterial cellulose has been demonstrated as well [62-66].  
When implanted subcutaneously in rats, Helenius et al. found that fibroblasts infiltrated BC and it 
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did not elicit inflammation, incur giant cells, or cause fibrotic capsulation [62].  Klemm et al. had 
positive in-vivo results with their product BASYC® which consists of hollow tubes of bacterial 
cellulose [63].  It was determined that BASYC® could successfully be used as blood vessel and 
nerve replacements [63].  Novaes et al. and Mello et al. found that BC could be used to substitute 
periodontal tissues [64] and the dura mater [65] in dogs.  A recent rabbit in-vivo study concluded 
that a double network hydrogel consisting of bacterial cellulose and polyacrylamide gel had the 
appropriate properties to substitute cartilage [66]. 
 One of the most promising medical applications of bacterial cellulose is in wound healing 
[67].  Bacterial cellulose dressings are an effective treatment for severe body burns, diabetic 
ulcers, abrasions, and lesions.  A skin substitute based on BC called XCell® (Xylos Corporation: 
Langhorne, PA, U.S.A.) has been approved by the Food and Drug Administration and is currently 
on the market  [47].  XCell® is a high performance dressing which maintains the moisture balance 
in the wound to speed up healing and epithelialization [47]. 
 
1.4.2.  Oxidized Cellulose 
A major limitation of using bacterial cellulose as a tissue substitute is the inability of 
cellulose to degrade in mammalian systems.  Humans lack the enzyme necessary to cleave the 
β-1,4 glycosidic bonds between glucose residues in the cellulose polymer.   An ideal tissue 
substitute should stimulate appropriate cell ingrowth, degrade as new tissue is produced, and 
then be safely resorbed by the body.   
Various approaches have been employed to make cellulose susceptible to degradation in 
vivo [68].  These include treatment with nitrogen dioxide, periodic acid, chromic acid, 
hypochlorite, and alkaline hypobromite [68].  Chemical modification of cellulose fibrils using 
oxidizing agents has been shown to increase the biodegradability of this material. Some oxidants, 
such as chromic acid and alkaline hypobromite, tend to only react with amorphous regions and 
crystallite surfaces of cellulose and disrupt the physical structure of cellulose, often reducing it to 
powder [68]. In contrast, oxidizing reagents such as periodic acid and nitrogen dioxide are able to 
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penetrate and react with crystalline as well as amorphous regions of cellulose.  They also have a 
significant advantage over other oxidizing agents in that minimize degradation and retain the 
mechanical and morphological properties of the starting material [68]. 
Surgicel™ is a commercially available hemostat used for a variety of surgical procedures 
(Ethicon, Inc.: Somerville, NJ, U.S.A.) [69].  It is produced by reacting regenerated plant cellulose 
with nitrogen tetroxide under controlled conditions which converts the primary hydroxyl group of 
cellulose into a carboxylic acid [68,70] (Figure 1.8).  Several studies have explored the use of 
Surgicel™ for other medical applications including treatment of skin graft donor sites [71] and to 
supplement cartilage grafts [72].  Interceed® (Ethicon, Inc.: Somerville, NJ, U.S.A.) is another 
commercial FDA-approved product consisting of nitrogen tetroxide-oxidized regenerated cellulose 
which is used during gynecological pelvic surgery to reduce the incidence of postoperative pelvic 
adhesions [73].   Microdispersed cellulose oxidized with nitrogen tetroxide is found in the over-
the-counter first-aid product, Seal-On™ (Alltracel Pharma Ltd: Dublin, Ireland), which is a 
hemostatic dusting powder used to treat cuts, abrasions, lacerations, or burns [74].  In a study by 
Dias and Peplow, it was reported that plant cellulose oxidized with nitrogen dioxide had the 
capacity to heal bone defects with complete replacement by lamellar bone at 6-8 weeks [75]. 
Aside from the highly corrosive and poisonous properties of nitrogen tetroxide, it also 
initiates many side reactions which produce additional reaction products, functional groups, 
and/or side chains [70].   These side reactions are difficult to control and can profoundly affect the 
properties of the product [68].  Conversely periodic acid (HIO4) specifically reacts with molecules 
that have adjacent hydroxyl groups [76].  When applied to cellulose, the C2-C3 bond in the 
glucose residue is cleaved and the adjacent hydroxyl groups are converted to aldehydes 
producing dialdehyde cellulose (DAC) (Figure 1.9) [76].  There is evidence that DAC hydrolyzes 
at pH 7.4 into glycolic acid and 2,4-dihydroxybutyric acid [77].  These are natural metabolic 
products found in mammalian systems and can be safely excreted from the body [77].   
Periodate oxidation has been performed on several types of cellulose including cotton 
linters [78], microcrystalline cellulose [79], cellulose powder derived from cotton [80], cellulose 
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 Figure 1.8:  Oxidation of cellulose by nitrogen tetroxide [adapted from reference 68] 
 
 
 
Figure 1.9:  Periodate oxidation of cellulose [adapted from reference 68] 
 
 
powder from beech wood pulp [80], and crystalline cellulose isolated from Cladophora sp. algae 
[76].  Regenerated plant cellulose has also been oxidized using periodate [77, 81].  Laurence et 
al. studied the effectiveness of periodate oxidized cellulose regenerated by the viscose process 
(CRVox) as a hemostat for osseous environments [77].  It was found that CRVox was a superior 
hemostat over Surgicel™ in bony sites, however bone only formed on the outlying areas of both 
implants with granulation tissue filling the central zones after one month [77].  
 
1.4.3.  Mineralized Bacterial Cellulose for Bone Substitution 
Many synthetic and natural hydrogels undergo calcification after physiological 
implantation.  While calcification can result in dystrophic failure of medical devices such as heart 
valves or vascular grafts, the deposition of calcium phosphate minerals is desirable for osseous 
or dental biomaterials [82].  In this dissertation, a composite consisting of calcium-deficient 
hydroxyapatite deposited in bacterial cellulose is proposed for use as a bone graft alloplast.  
Another embodiment consisting of oxidized bacterial cellulose with calcium-deficient 
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hydroxyapatite is presented whose degradation properties may be more suitable for bone 
replacement. 
It was reported that bacterial cellulose had the capacity to initiate the formation of 
calcium-deficient hydroxyapatite in the candidate’s master’s thesis [61] and U.S. Patent 
Application [83].  In both of these documents, it was reported that apatite could be precipitated in 
bacterial cellulose by several techniques including: (i) incubation of BC in aqueous CaCl2 followed 
by incubation aqueous Na2HPO4, (ii) incubation of BC in aqueous CaCl2 followed by incubation in 
aqueous K2HPO4, (iii) incubation of BC in aqueous CaCl2 followed by incubation in aqueous 
Na5P3O10, (iv) incubation of BC in aqueous Ca(OH)2 followed by incubation in aqueous Na2HPO4, 
(v) incubation of BC in simulated body fluid, (vi) incubation of phosphorylated BC in aqueous 
CaCl2, (vii) incubation of phosphorylated BC in aqueous CaCl2, (viii) incubation of phosphorylated 
BC in aqueous CaCl2, (ix) incubation of phosphorylated BC in aqueous Ca(OH)2, (x) incubation of 
phosphorylated BC in simulated body fluid, and (xi) incubation of phosphorylated BC in aqueous 
Ca(OH)2 followed incubation in simulated body fluid.  One of these mineralization techniques, 
incubation of BC in aqueous CaCl2 and then in aqueous Na2HPO4, was thoroughly characterized 
and studied for this dissertation [84].  Another variation is reported entailing the mineralization of 
periodate oxidized bacterial cellulose by incubation in aqueous CaCl2 and aqueous Na2HPO4. 
Since the publication of the candidate’s master’s thesis and patent application, four 
related articles have been published regarding the formation of hydroxyapatite-bacterial cellulose 
composites.  Bodin et al. surface modified the BC by ozone-induced graft polymerization of 
acrylic acid, pre-soaked the modified BC in Ca(OH)2, then incubated it in simulated body fluid 
[85].  SEM showed the formation of crystals around the BC fibrils which had a calcium to 
phosphate ratio of 1.5, but the identification of the mineral was never confirmed [85].  Hong et al. 
mineralized BC by presoaking it in 0.1 M CaCl2 followed by incubation in simulated body fluid.  
SEM showed the formation of spherical particles which had penetrated into the BC matrix.  X-ray 
diffraction (XRD) identified the particles as 20 nm crystallites of calcium-deficient hydroxyapatite.  
FTIR showed that the hydroxyapatite was carbonate substituted [86].  A similar study by the 
 24
same group first phosphorylated the BC then incubated it in 0.1 M CaCl2 and simulated body fluid 
[87].  This modification caused the calcium to deposit as a fiber coating as opposed to discrete 
spherical particles.  The crystal phase was identified as hydroxyapatite by XRD and FTIR 
confirmed carbonate substitution [87].  A last study by Nge and Sugiyama added carboxylate 
groups to BC by either culturing the bacteria in the presence of carboxymethyl cellulose salt (BC-
CMC) or by oxidizing the cellulose with TEMPO (2,2,6,6-tetramethylpyperidine-1-oxyl) (BC-
TEMPO) [88].  The native BC, BC-CMC, and BC-TEMPO were incubated in 0.1 M CaCl2 followed 
by immersion in simulated body fluid.  Globules formed in all of the samples, though the size 
depended on the modification.  TEM showed that the globules were composed of thin filmed 
flakes which ranged in size from 60-140 nm [88].  FTIR showed the presence of an HPO42- and 
carbonate groups indicating the mineral was carbonated calcium-deficient hydroxyapatite.  FTIR 
also showed that there was a precursor octacalcium phosphate phase [88]. 
 This dissertation study explores the use of a mineralization technique not previously 
reported (use of aqueous calcium chloride and sodium phosphate dibasic), as well as the use of a 
degradable bacterial cellulose matrix which underwent periodate oxidation.  The physical, 
chemical, and degradation properties of these composites are presented.  Another chapter 
reports a statistical optimization of bacterial cellulose production using fractional factorial design.  
The last chapter offers a discussion of the possible clinical applications of BC-CdHAP in bone 
substitution. 
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Chapter 2 
Materials and Methods 
 
 
This chapter describes the techniques used to produce and analyze the materials.  
Sample synthesis entails the culturing of bacterial cellulose, either chemically modifying the 
bacterial cellulose (via periodate oxidation) or leaving it in its native form, and finally mineralizing 
the cellulose to produce calcium-deficient hydroxyapatite.  The instruments and techniques used 
to characterize the samples described.  Procedures used to determine the degradation properties 
of the chemically modified cellulose are also given.   
 
2.1.  Sample Preparation 
2.1.1.  Cultivation of Bacterial Cellulose  
The bacterial strain Gluconacetobacter hansenii (G. hansenii) was obtained from the 
American Type Culture Collection (Manassas, VA, U.S.A.) (ATCC 10821) to synthesize bacterial 
cellulose.  The bacteria were cultivated on Schramm-Hestrin Media [89].  This nutritional broth is 
made by combining the reagents listed in Table 2.1.  An optimized formulation that substitutes 
mannitol for glucose was used in this study [90].  The reagents were dissolved in 
distilled/deionized water, the volume was brought up to one liter, and the pH was adjusted to 6.0 
with the addition of hydrochloric acid or sodium hydroxide.  The media was then autoclaved at 
121°C for 20 minutes.   
The bacteria were maintained on Mannitol 1 Agar as recommended by ATCC.  The  
 
Table 2.1:  Reagents used in Schramm-Hestrin 2% Mannitol Medium [89] 
 
Reagent Amount 
Mannitol 20 g 
Yeast Extract 5 g 
Peptone 5 g 
Sodium Phosphate Dibasic 2.7 g 
Citric Acid 1.15 g 
Distilled Water 1 L 
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reagents in Table 2.2 were dissolved in water, and brought to a 1 L volume.  The mixture was 
then autoclaved at 121°C for 15 minutes and poured into culture dishes.  A preculture was then 
streaked onto the agar plates with bacterial inoculation loops.  Without further maintenance, 
colonies began to form on the agar within a few days.  New precultures were made by removing a 
single colony from the agar plates, placing it in 10 ml of Schramm-Hestrin medium, and allowing it 
to culture under agitated conditions provided by an orbital shaker.   
For synthesis of cellulose pellicles, larger precultures were made by adding to 50-200 ml 
of Schramm-Hestrin medium to the 10 ml preculture in a flask under agitated conditions.  After 2-
3 days of incubation, the preculture was diluted in a 1:10 ratio with the prepared Schramm-
Hestrin medium and poured into appropriate culture dishes.  The static cultures were kept at 
room temperature (~23°C) for a given amount of time.   The cellulose was then harvested by 
lifting the pellicle off the liquid surface with forceps.  
 
2.1.2.  Purification of Bacterial Cellulose 
After harvesting, the cellulose pellicles were placed in a beaker of distilled/deionized 
water, put into a water bath, and heated to 90°C for 1-2 h to kill the bacteria.  The pellicles were 
then rinsed with distilled/deionized water, and treated with a sodium hydroxide to remove 
bacterial debris and growth media components.  The pellicles were incubated in 1% NaOH under 
agitated conditions at room temperature (23°C).  Every 24 h, the NaOH was decanted and fresh 
solution was added.   This process was continued until the cellulose was purified.  
Polypeptides and DNA left in the bacterial cellulose after cultivation absorb in the UV 
 
Table 2.2:  Reagents used in ATCC Mannitol 1 Agar [protocol from the American Type Culture 
Collection: Manassas, VA, U.S.A.] 
 
Reagent Amount 
Yeast Extract 5 g 
Peptone 3 g 
Mannitol 15 g 
Agar 15 g 
Distilled Water 1 L 
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region.  Their presence in the used sodium hydroxide solution indicated the purity of the bacterial 
cellulose.   The absorbance at 280 nm was read on Carey50 Spectrophotometer (Varian: Palo 
Alto, CA, U.S.A.) (Figure 2.1).  A high absorbance indicated that the NaOH had removed a great 
deal of impurities.  As the absorbance decreased with daily NaOH changes, it was assumed that 
less proteins and nucleic acids remained in the cellulose (Figure 2.1).  An absorbance reading of 
approximately 0.05 - 0.10 signified that enough debris had been removed to deem the cellulose 
pure. 
After the sodium hydroxide treatment, the cellulose was soaked in several changes of  
distilled/deionized water to neutralize the NaOH in the cellulose.  The washings continued until 
the pH was near neutrality (pH ~7).  The cellulose was stored in distilled/deionized water under 
refrigeration (5-10°C). 
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Figure 2.1: Absorbance scans of daily changes of 1% NaOH for bacterial cellulose purification 
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2.1.3.  Oxidation of Bacterial Cellulose 
To chemically modify the cellulose into a degradable hydrogel, periodate oxidation was 
performed.  The method used was modified from a protocol given by Painter in 1988 [91].  In  
brief, cellulose pellicles were placed in a capped vessel containing 50 mM NaIO4 in 5% n-
propanol.  The vessel was covered in aluminum foil and placed on an orbital shaker for 24 h at 
23°C.  The reaction was stopped by adding 0.5 ml of glycerol and placing the vessel in an ice 
bath.  The cellulose was then purified with several changes of distilled/deionized water to remove 
the oxidation reagents.   
 
2.1.4.  Deposition of Calcium-Deficient Hydroxyapatite 
Bacterial cellulose pellicles were deposited with calcium-deficient hydroxyapatite 
(CdHAP) by sequentially incubating the cellulose in aqueous calcium chloride followed by 
incubation in aqueous sodium phosphate dibasic [61,83].  Different amounts CdHAP can be 
deposited into the cellulose by varying the concentration of the CaCl2 and Na2HPO4 solutions or 
varying the number alternating incubation cycles in the ion solutions.  An incubation cycle is 
defined as suspending the BC for 24 h in 100 mM CaCl2 (pH 4.83) under agitation followed by 
incubation in 60 mM of Na2HPO4 (pH 8.36) for 24 h under agitation at room temperature (23°C).  
After mineralizing the cellulose, it is rinsed in several changes of distilled/deionized water. 
 
2.2.  Material Characterization 
2.2.1.  X-Ray Diffraction 
X-ray diffraction can be used to identify a substance based on its crystal structure, to  
measure the size and dimensions of the crystal, as well as qualitatively compare the degree of 
crystallinity of polymers [92].  Crystals have a distinct arrangement of atoms with specific 
distances between them.  When an x-ray beam is directed through a crystal, the different 
interatomic distances produce a series of reflections to form a diffraction pattern [92].  The 
position and intensity of the diffraction peaks are indicative of the unique crystal structure [92].  
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Hundreds of thousands of diffraction patterns have been collected in the Powder Diffraction File 
(PDF) (International Centre for Diffraction Data File: Newtown Square, PA, U.S.A.).  By using 
indexes like the Hanawalt Index, or database software such as Jade 6.0 (Materials Data 
Incorporated: Livermore, CA, U.S.A.), it is possible to identify a material based on its x-ray 
diffraction pattern. 
Crystallite size, crystallite strain, and instrumental factors contribute to the broadening of 
x-ray diffraction peaks [92].  The Scherrer Equation is used to calculate the thickness of 
crystallites from the peak breadth: 
 θβ
λ=
cos
9.0t    {2.1} 
where t is the diameter of the crystallites, λ is the wavelength of the x-ray beam, and β is the 
corrected breadth of the broadened diffraction peak at a specific 2θ value [92].  Assuming that the 
peaks are Gaussian, β is calculated by: 
β2 = B2 – b2   {2.2} 
Where B is the measured full width at half maximum (FWHM) of the peak and b is 
instrumental broadening.  Instrumental broadening can be measured by evaluating a sample with 
a relatively large grain size [92].  
In order for these thicknesses to hold true, several assumptions must be made.  First, all 
the broadening in the peaks must come from particle size.  The broadening cannot be attributed 
to crystal strain or inhomogeneity of the composition.  Second, the peaks must be Gaussian in 
shape.  By measuring the thickness in different plane directions from different peaks, the 
geometry and size of the crystallites can be determined [92].  Jade® software utilizes Scherrer’s 
Equation to calculate the crystallite size of the CdHAP in each plane direction.  The program 
referred to an XRD pattern of a single crystal silicon standard to correct for instrumental 
broadening.   
Hydrated samples of BC and bacterial cellulose-hydroxyapatite composites (BC-CdHAP) 
were placed on a gel-dryer (Drygel Jr., Model SE540, Hoefer Scientific Instruments: San 
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Francisco, CA, U.S.A.) for 30 minutes at 80°C with application of a 68 kPa vacuum.  The samples 
were mounted on a silicon zero-background holder.  Room Temperature X-Ray Diffraction data 
were obtained on a Scintag PADV instrument operated at 45 kV and 40 mA with CuKα radiation 
and a Si(Li) Peltier-cooled solid state detector.  Data were collected between 10 and 70° 2θ at a 
scan rate of 1° 2θ/min.  Jade software was used to identify the crystal structure of the cellulose 
and calcium-deficient hydroxyapatite (CdHAP) by comparing patterns to those present in the 
Powder Diffraction File (PDF).  Jade® was also used to calculate the CdHAP crystallite size for 
each reflection.  JMP software (SAS: Cary, NC, U.S.A.) was used to determine statistical 
significance of the CdHAP crystallite sizes by performing Tukey-Kramer tests at α=0.05.   
 
2.2.2.  Scanning Electron Microscopy 
Scanning Electron Microscopy (SEM) provides three-dimensional quality surface images 
with excellent resolution and depth of field.  During SEM, a focused high energy electron beam is 
scanned across a sample which causes secondary electrons to be emitted.  A detector is used to 
measure the intensity of the secondary electron emission which is dependent on the sample’s 
composition and geometry [93].  Surface topography can be observed under magnifications of up 
to 100,000x [93].    
To produce samples to be analyzed with SEM, the samples were first lyophilized.  Briefly, 
the hydrated samples were placed in a -80°C freezer for 24 h.  They were then placed on a 
freeze-dryer (Refrigeration for Science: Island Park, NY, U.S.A.) where the water was pulled off at 
40 Pa under -50°C refrigeration for 24 h.  The samples were then mounted on carbon tape and 
sputtered with gold on a Spi Module Sputter Coater (Spi Supplies: Westchester, PA, U.S.A.) at 20 
mA for 10 s.  They were then analyzed on a LEO 1525 Scanning Electron Microscope (Zeiss: 
Oberkochen, Germany) at various accelerating voltages as indicated in the micrographs.  To 
obtain the 50,000x magnification on the BC-CdHAP sample, it was mounted on silver paint and 
sputtered with gold at 20 mA for 15 s.  Energy Dispersive Spectra was also used to determine the 
calcium to phosphorus ratio of the hydroxyapatite particles. 
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2.2.3.  Fourier Transform Infrared Spectroscopy 
Infrared (IR) spectroscopy is an established method used in material characterization.  
When molecules interact with infrared light, vibrations occur at specific frequencies based on the 
arrangement of atoms and their interconnecting bonds [94].  In order to be infrared active, the 
absorbed radiation must induce a change of dipole in the molecule.  The IR spectra shows the 
frequencies at which the various functional groups in the sample absorbs the radiation and the 
intensities of the absorptions.  IR spectroscopy can be used to determine a material’s chemistry 
and structure orientation.  It can also provide information regarding bonding interaction.  
Identification of materials can be achieved by comparing the data to reference spectra.  IR 
spectroscopy can be used to characterize the bulk specimen, the surface, or used perform depth 
profiling [93].   
Hydrated samples of BC and BC-CdHAP were placed in a -80oC freezer for 24 h and 
then granulated in a commercial blender for 1-2 minutes.  The frozen powders were then 
lyophilized as indicated in the previous section and then further dried for 24 h in a vacuum oven 
(100°C at 68 kPa).   
Approximately 1 mg of powdered sample was combined with 45 mg KBr powder and 
compressed into a pellet using a screw-type press.  Fourier Transform Infrared Spectroscopy was 
performed on a BioRad FTS6000 Spectrometer (BioRad: Randolph, MA, U.S.A.).  The spectra 
are the result of 256 scans collected with a resolution of 4 cm-1.   
Functional groups of the cellulose and hydroxyapatite were identified as absorption 
bands at specific wavenumber positions.  Changes in the chemical environment of functional 
groups within a sample are reflected in its IR spectrum.  If the characteristic bands of a specific 
functional group shift to lower wavenumbers, it can be concluded that there is a change in the 
molecular environment, such as the formation of a new inter or intramolecular chemical bond [95]. 
Deconvolution of the cellulose hydroxyl bands (3600-3100 cm-1) was performed with the 
use of PeakFit® v.4.6 software (SeaSolve Software: Framingham, MA, U.S.A.).  PeakFit® 
separated overlapping peaks by statistically fitting peak functions to the data set.  The program 
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initially placed peaks by finding local maxima in a smoothed data stream.  Hidden peaks were 
found by searching for local minima within the smoothed second derivative of the data set.  The 
deconvolution procedure then used a Gaussian-Lorentzian response function with a Fourier 
deconvolution and fitting algorithm.  This ensured that the sharpened peaks had the equivalent 
area of the overlapping peaks [96]. 
 
2.2.4.  Mechanical Testing 
 The mechanical behavior of a biomaterial is of great importance.  Mechanical testing 
provides information as to how the appliance will perform under load when it is placed in the 
physiological environment.  Once implanted, the material will be exposed to various stresses and 
strains.  Successful biomaterials often mimic the mechanical properties of the substituted tissue.  
During tensile testing, an applied stress causes a change in the original length of the specimen 
which can be measured to find the strain.  These parameters can then be used to calculate the 
elastic modulus, ultimate tensile strength, and elongation.   The elastic modulus, or Young’s 
Modulus, is an inherent material property which characterizes stiffness or brittleness in a given 
direction. 
During testing in tension mode, a specimen is subjected to a continually increasing 
uniaxial tensile force while simultaneous observations are made of the elongation of the 
specimen.  The stress-strain curve is constructed from the load elongation measurements.  A 
typical stress-strain curve is shown in Figure 2.2.  The engineering stress (σe) is found by 
measuring the load (F) and dividing it by the original area of the cross-section of the specimen 
(Ao): 
 
  σe = F / Ao   {2.3} 
 
The engineering strain (εe) is determined by dividing the elongation of the sample (L – Lo) 
by the original gage length Lo where L is the gage length after elongation: 
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 Figure 2.2: Stress-strain curve of a material showing how the elastic modulus and ultimate 
tensile strength can be extrapolated 
 
 
  εe = (L - Lo) / Lo   {2.4}  
 
The engineering stress is related to the engineering strain by the engineering modulus of 
elasticity (Ee) as is shown: 
 
  σe = Ee εe   {2.5} 
 
The engineering modulus of elasticity is typically determined from the stress strain curve 
by calculating the slope of the initial linear portion of curve (Figure 2.1).  The ultimate tensile 
strength is the peak stress of the engineering stress-strain curve (Figure 2.1). 
 
 
2.3.  In-Vitro Degradation Study of Oxidized Cellulose Samples 
The degradation behavior of the samples was analyzed by immersion in HEPES buffer.  
Originally, phosphate buffered saline (PBS) was used.  However, it was determined that the salt 
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in PBS adsorbed onto the oxidized cellulose membranes and could not be easily removed by 
washing in water.  Low-salt HEPES buffer consisting of 25 mM HEPES and 75 mM NH4Cl was 
selected to reduce salt adsorption.  The solution was titrated to pH 7.4 using hydrochloric acid or 
sodium hydroxide and then subsequently autoclaved at 121°C for 20 minutes.   
Two separate studies were carried out on two identical batches of samples.  The samples 
consisted of native bacterial cellulose (BC), oxidized bacterial cellulose (oxidized BC), native 
bacterial cellulose with calcium-deficient hydroxyapatite (native BC-CdHAP), and oxidized 
bacterial cellulose with calcium-deficient hydroxyapatite (oxidized BC-CdHAP).  All of the samples 
were autoclaved in HEPES buffer.  Each of the samples were then placed in a sterile 50 ml 
conical tube and added to 5 ml of sterile HEPES buffer.  Half of the samples from each group 
were placed in a 37°C Forma Scientific Water Jacketed Incubator (Thermo Electron Corporation: 
Waltham, MA, U.S.A.) for static incubation.  The remaining samples from each group were placed 
in a 37°C controlled environment incubator shaker (New Brunswick Scientific Co., Inc.: Edison, 
NJ, U.S.A.) for dynamic incubation. 
In the first study, the buffer was removed from the samples and analyzed at specific time 
points.  Every other day, the samples were separated from the HEPES buffer by centrifugation at 
3500 x g for 15 min.  The absorbance of the supernatant was measured on a Cary 
spectrophotometer (Varian: Palo Alto, CA, U.S.A.) from 190-350 nm.  Five milliliters of fresh 
sterile HEPES buffer was then added to each sample of cellulose before being returned to the 
incubators.  The samples were removed from the HEPES buffer after fourteen days of incubation, 
rinsed in several changes of distilled/deionized water, dried, and weighed.  
The initial set-up of the second study was identical to the first.  The only difference was 
that the samples remained in the original buffer throughout the 14 days.  At the end of the 14 day 
period, the buffer was removed from the sample by centrifugation at 3500 x g for 15 min.  The 
buffer was then analyzed for degradation products: free carbohydrate and glycolic acid.  
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2.3.1.  Identification of Degradation Products  
It has been reported that dialdehyde cellulose hydrolyzes at pH 7.4 to yield glycolic acid 
and 2,4 dihydroxybutyric acid [77,78,97].  A proposed mechanism is shown in Figure 2.3.  It has 
also been theorized that dialdehyde cellulose also breaks down into smaller soluble molecules 
(free carbohydrate) [77].  To verify whether periodate oxidized bacterial cellulose produced these 
degradation products, the separated buffer obtained in the second in-vitro degradation study was 
spectrophotometrically analyzed.  These assays had previously been used to analyzed the 
degradation products of periodate oxidized regenerated plant cellulose [77]. 
To determine the amount of free carbohydrate, 0.5 ml of the separated HEPES buffer 
was added to 2 ml of 0.16% anthrone (Fisher Scientific: Waltham, MA, U.S.A.) in concentrated 
sulfuric acid.  Standard solutions (0.5 ml volume) with concentrations ranging from 5-100 μg/ml 
glucose in low salt HEPES buffer were also added to 2 ml of the anthrone solution.  The mixtures 
were vortexed, incubated at 90°C for 20 min, then allowed to cool.  The absorbances of the 
solutions were measured at 587 nm using HEPES buffer as a blank.  The concentrations were 
determined from a standard curve. 
To determine the amount of glycolic acid released, 0.2 ml of the HEPES supernatant was 
 
 
Figure 2.3: Proposed degradation mechanism of dialdehyde cellulose into 2,4-dihydroxybutyric 
acid and glycolic acid [adapted from reference 97] 
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added to 2 ml of 0.01% 2,7-dihydroxynaphthalene (Acros Organics: Geel, Belgium) in 
concentrated sulfuric acid.  Standard solutions (0.2 ml volume) with concentrations ranging from 
5-100 μg/ml glycolic acid (Fisher Scientific: Waltham, MA, U.S.A.) in HEPES buffer were also 
added to 2 ml of the 2,7-dihydroxynaphthalene solution.  The mixtures were vortexed, incubated 
at 90°C for 20 min, then allowed to cool.  Four ml of 4 N H2SO4 was then added to each sample, 
vortexed, and allowed to cool.  The absorbances of the solutions were measured at 530 nm using 
HEPES buffer as a blank.  The concentrations were determined from a standard curve. 
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Chapter 3 
Statistical Determination of Optimal Bacterial Cellulose 
Production from Gluconacetobacter hansenii 
 
 
 In order to produce a medical product based on bacterial cellulose, it is necessary to 
culture the bacteria on a large scale.  Cultivation conditions must be optimized to produce the 
most cellulose in the shortest amount of time at the most economical cost.  Many different 
nutritional media components and environmental conditions have been used in cellulose 
production.  The aims of this study were to statistically design and execute an approach whereby 
several different parameters could simultaneously be tested to determine the best conditions for 
cellulose growth from Gluconacetobacter hansenii (ATCC 10821).  In this work, it was of interest 
to determine the effect of five culture factors.  The results of this study were published in the 
journal Letters in Applied Microbiology [90]. 
 
3.1.  Selection of Factors to Test 
Glucose is typically used as a carbon source in nutritional growth medium for the bacteria 
[89].  However, a sugar alcohol such as mannitol may stimulate increased cellulose production.  
The bacteria contain alcohol dehygrogenase enzymes capable of oxidizing alcohol to produce 
electrons which could provide an energy “boost” for the bacteria [98].  Presence of ethanol in the 
culture may likewise enhance cellulose synthesis.  Previous studies have shown that the addition 
of ethanol removes non-cellulose producing bacterial cells which increases overall cellulose 
synthesis [99].  When the bacteria produce the cellulose, they also produce acidic byproducts 
such as gluconic acid and acetic acid.  This decreases the pH and may eventually inhibit 
cellulose production.  By using a more basic medium, this acidity may be decreased and more 
cellulose may be produced.  Culturing at a higher temperature may also provide better 
production.  It has been shown that at lower temperatures, the bacteria are not as mobile which 
may hinder the metabolic activity necessary for cellulose production [100].  Cellulose production 
may also be enhanced by increasing the ratio of bacterial inoculant to the nutritional growth 
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medium.  By having larger populations of bacteria, a greater amount of cellulose could be 
produced.  For these reasons, this study analyzed the effects of five culture factors: carbon 
source in the growth medium, ethanol addition to the growth medium, inoculation ratio of the 
bacteria, pH of the growth medium, and temperature on the amount of cellulose produced by G. 
hansenii. 
 
3.2.  Fractional Factorial Design 
In experiments with two or more independent factors, factorial design can be used to plan 
experiments such that the effect of the factors and each factor interaction can be elucidated.  In 
full factorial design, every value of every factor appears with each value setting of every other 
factor to test all possible combinations.  For example, if there are n factors and each factor has 
two possible values, a full factorial analysis would have 2n sample runs.  Factorial design is 
especially suited for the investigation of the optimal growth conditions of microbial cultures since 
the interactions of several independent factors may all play a role.  However, this technique can 
be unwieldy if the system contains several factors.  Fractional factorial design is better suited for 
a system of five or more factors.  It is a more efficient approach which uses only a portion of the 
combinations which are selected to ensure each two factor interaction is represented.  Since five 
culture condition parameters were tested in this study, a five-factor, half-fraction resolution five 
design was used to construct the experiment.  This design permits the estimation of each of the 
main effects and the two factor interactions if it is assumed that three factor interactions and 
higher are negligible.   
JMP Software (SAS: Cary, NC, U.S.A.) was used to design this five-factor, resolution-five 
fractional factorial design.  The five factors investigated were carbon source, ethanol addition, 
inoculation ratio, pH, and temperature.  Table 3.1 shows the 16 specific culture conditions 
designed to assess all main effects and two-factor interactions.  Three replicates of each culture 
condition were made for a total of 48 cultures.   
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Table 3.1:  Culture conditions of each fractional factor combination and subsequent mass of 
cellulose produced [90]  
 
Carbon 
Type 
Ethanol 
Present 
Inoculation 
Ratio 
pH Temperature 
(°C) 
Mean Cellulose 
Mass (mg) 
Glucose No 1:10 5.5 30   3.2 
Glucose No 1:10 6.5 20 13.5 
Glucose No 1:5 5.5 20 12.8 
Glucose No 1:5 6.5 30   6.1 
Glucose Yes 1:10 5.5 20   5.3 
Glucose Yes 1:10 6.5 30   4.0 
Glucose Yes 1:5 5.5 30   3.0 
Glucose Yes 1:5 6.5 20   8.8 
Mannitol No 1:10 5.5 20 16.0 
Mannitol No 1:10 6.5 30   7.9 
Mannitol No 1:5 5.5 30 12.7 
Mannitol No 1:5 6.5 20 14.8 
Mannitol Yes 1:10 5.5 30   8.6 
Mannitol Yes 1:10 6.5 20 14.3 
Mannitol Yes 1:5 5.5 20 13.5 
Mannitol Yes 1:5 6.5 30   7.0 
 
3.3.  Bacterial Cellulose Synthesis 
After the cultures were inoculated, visible clouds of cellulose began to form within one to 
two days.  A thick “skin” of cellulose formed on the surface of the media within 5-7 days (Figure 
3.1).  After purifying the samples as described in section 2.2.1, the cellulose is a transparent and 
slippery gelatinous pad (Figure 3.1).  To analyze the dry mass of the cellulose, the samples were 
dehydrated by using a gel-dryer (Drygel Jr., Model SE540, Hoefer Scientific Instruments) for 30 
minutes at 80°C with application of a vacuum (20 inches Hg).  The dry weight of each sample 
was then measured and recorded in milligrams (mg) on a Mettler AE200 electronic analytical 
balance (Mettler-Toledo: Toledo, OH, U.S.A).  Box plots of the resulting cellulose yields are given 
in Figure 3.2. 
 
3.4.  Statistical Analysis of Results 
JMP software was used to fit the data to a statistical model which included all the main 
factors and each two-factor interaction.  Due to the efficient planning of the experiment, there 
were no degrees of freedom for error since it was a resolution five design.  A normal plot of the  
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Figure 3.1: Bacterial cellulose culture consisting of Gluconacetobacter hansenii in Schramm-
Hestrin Medium (left) with purified bacterial cellulose (right)  
 
 
 
 
Figure 3.2:  Mass of cellulose produced under different culture conditions [90] 
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parameter estimates of the model was used to screen the effective factors (Figure 3.3).  If all the 
effects were random, the entire plot would follow a straight line with a slope equal to the standard 
error.  Effects that deviate substantially from this line indicate significant factors and are shown in 
Figure 3.3.  It was seen that temperature, ethanol addition, and carbon source were active factors 
in cellulose production since their factor values significantly deviated from the normal line.  The 
plot also indicated that the carbon source – pH factor interaction may also have actively 
contributed to cellulose growth. 
To investigate these phenomena further, a new model was constructed using these 
active factors and the active factor interaction: carbon source, ethanol addition, temperature, and 
the carbon source – pH factor interaction.  Although pH itself is not an active factor, it was 
included in this model to ensure a hierarchical model since its interaction with carbon was 
significant.  Removing the insignificant inoculation ratio factor and remaining two-factor 
interactions allowed estimation of error in the model and permitted the use of an analysis of 
variance test to assess the significance of the factors (Table 3.2).  The null hypothesis of this test  
 
 
Figure 3.3: Normal plot of the parameter estimates obtained from the fitted model.  The following 
factors and factor interaction deviate from the straight line and contribute significantly to the 
model: 20°C Temperature (▼), No Ethanol (*), Glucose and pH 5.5 Interaction (¤), Glucose (●) 
[90] 
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Table 3.2:  Effects test for the reduced statistical model [90] 
 
Source Degrees of Freedom Sum of Squares F-Ratio Prob > F 
Carbon 1 92.00007 34.8132 0.0002
Ethanol Added 1 31.26674 11.8314 0.0063
Temp (°C) 1 133.98062 50.6988 <.0001
pH 1 0.09507 0.0360 0.8534
Carbon*pH 1 13.87563 5.2506 0.0449
 
 
Figure 3.4:  Least squares means plot of the carbon source and pH factor interaction [90] 
 
was that the included factors and two-factor interactions do not contribute to the model.  This was  
tested by calculating the F- ratio on JMP.  Briefly, the F-ratio was obtained by dividing the mean 
square for the effect by the mean square for error.  The mean square for the effect was calculated 
by dividing the sum of squares for each effect by its degrees of freedom.  If the p-value (Prob > F) 
of the F-ratio was less than the alpha level (α = 0.05), the null hypothesis would have been 
rejected proving that the parameter contributed a significant effect.  From Table 3.2, it can be 
concluded that carbon source, ethanol addition, and temperature were all very significant factors 
in the model.  Though pH on its own was not significant, it was seen that the pH interaction with 
carbon was significant.   
The specific dependence of carbon on pH was elucidated by constructing a least squares 
means plot of the carbon – pH interaction given in Figure 3.4.  It is seen that the average 
cellulose produced for both carbon sources at pH 5.5 is relatively the same as that at pH 6.5.  
However, there is significant variation between cultures grown on glucose at pH 5.5 and 6.5 and  
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between cultures grown on mannitol at different pH values.  Bacteria cultured on a glucose 
medium at pH 6.5 produced more cellulose than at pH 5.5.  A medium containing mannitol shows 
the opposite behavior, causing the bacteria to produce more cellulose at the lower pH 5.5 as 
opposed to 6.5.   
The model can be fitted with the following mathematical equation: 
 
y = 9.47 - 2.40 x1 + 1.40 x2 + 2.89 x3 – 0.08 x4 – 0.93 x1x4  {3.1} 
 
where y is the mass of cellulose produced in milligrams and x1, x2, x3, and x4 are dummy 
variables representing carbon source, ethanol addition, temperature, and pH factors respectively.  
The values of x1, x2, x3, and x4 are as follows:  
 
                                           1 for Glucose  
Carbon source: x1 =   
              -1 for Mannitol 
 
 
                                          1 for No  
Ethanol added: x2 =   
              -1 for Yes 
 
 
                                         1 for 20°C 
Temperature: x3 =   
            -1 for 30°C 
 
                                        1 for pH 5.5  
pH:  x4 =   
            -1 for pH 6.5 
 
 
 An illustrative example of how the model equation predicts cellulose growth for each of 
the factor values is given in Figure 3.5.  It is seen that the most cellulose (17.02 ± 2.2 mg) would 
be produced using mannitol, with no ethanol, at a temperature of 20°C and a pH of 5.5.  Though 
pH solely does not affect cellulose production, mannitol coupled with a pH of 5.5 produces 
significantly more cellulose than if it were at pH 6.5. 
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 Figure 3.5:  Predicted cellulose mass using the statistical model with a given a set of factor 
values [90] 
 
3.5.  Discussion and Conclusion 
By planning the experiment using fractional factorial design, relevant data could be 
obtained using a smaller number of samples.  Full factorial design for the five parameters would 
necessitate 25 = 32 sample conditions.  With three replicates, 96 samples would have to be made 
in all.  While full factorial design would test every possible parameter combination, the experiment 
size would be large and not necessarily produce pertinent information.  Fractional factorial design 
instead tests all two parameter combinations producing 16 sample conditions.  With three 
replicates, only 48 cultures had to be made.  Fractional factorial design reduced the number of 
samples by half while still obtaining statistically significant results. 
By fitting the data to a statistical model, it was confirmed that carbon source, ethanol 
addition, and temperature are significant culture factors in the production of cellulose from this 
Gluconacetobacter hansenii strain.  Though pH on average did not show an active effect, the 
carbon source – pH factor interaction did significantly affect cellulose production.  When using 
mannitol, the optimal amount cellulose is produced at pH 5.5 while more cellulose is produced at 
pH 6.5 if glucose is used.  The bacteria produced the most cellulose when cultured on mannitol, 
without ethanol, at 20°C, and at a pH of 5.5.   
In Gluconacetobacter spp., cellulose synthesis competes for glucose with glucose 
oxidation by the membrane-bound glucose dehydrogenase that supplies metabolic processes 
 45
with electrons.  Repression of glucose oxidation by addition of ethanol or glycerol as an 
alternative electron source has been reported to increase cellulose yield [99].  These bacteria 
also contain membrane-bound alcohol and aldehyde dehydrogenases which can oxidize alcohol 
to acetic acid to obtain electrons [98].  Mannitol, a sugar alcohol, provided electrons for bacteria 
metabolism and stimulated a higher yield of cellulose compared to glucose which had been 
reported in a previous study [101].  It was predicted that presence of ethanol would likewise 
provide an energy source for the bacteria while they converted the carbon source to cellulose.  
Presence of ethanol increases cellulose production in shaken cultures by preventing the bacteria 
from forming a non-cellulose producing mutant [99,102].  Since static cultures do not normally 
produce the non-cellulose producing mutation, the ethanol did not show an appreciable effect in 
increasing cellulose production.  This is verified by a previous study with another cellulose-
producing strain, Acetobacter xylinus, which showed that ethanol had no significant effect on 
cellulose synthesis in static cultures [102]. 
The byproducts produced when glucose is oxidized by the bacterial enzymes also explain 
why each carbon source produced optimal cellulose yields at different pH values.  As the 
membrane-bound glucose dehydrogenase oxidizes glucose, gluconic acid is produced and 
expelled into the medium.  This can cause the pH to decrease to as low as 3 during cultivation 
[102] which may inhibit cellulose production.  By having a more basic medium, the acidity is 
decreased which improves cellulose production.  No acidification of the culture medium is 
observed during growth on mannitol.  This is consistent with the metabolic pathway for mannitol 
assimilation reported for the closely related genus Gluconobacter, in which mannitol is oxidized to 
fructose [103], which is then assimilated by the bacteria following a second oxidation to 5-keto-D-
fructose [104].   By precluding the formation of the sugar acid, the pH does not decrease 
drastically as with the glucose and cellulose growth is not inhibited.   
It was suspected that a higher temperature may stimulate the bacteria to produce more 
cellulose.  Hirai et al. showed that the bacteria are not as mobile at lower temperatures which 
may hinder the metabolic activity necessary for cellulose production [100].  However the converse 
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effect was proven to be true.  The elevated 30°C temperature actually inhibited the cellulose 
production by Gluconacetobacter hansenii while the 20°C environment produced significantly 
more cellulose.   
Inoculation ratio did not affect cellulose production as a factor or in a factor interaction.  
While it was expected that having a higher initial bacteria population in the culture would result in 
higher cellulose yields, there was no significant difference in the cellulose yields between the two 
inoculation ratios.  It is possible that each of the bacteria populations either divided to a critical 
value once inoculated, or that the discrete amount of medium was a limiting factor causing the 
bacteria to decrease.  In either case, it is likely the amount of bacteria in each culture equilibrated 
to approximately the same population number despite the initial inoculation ratio.   
Fractional factorial design enabled an efficient study of the effect of five culture 
parameters on the production of cellulose from Gluconacetobacter hansenii (ATCC 10821).  
Using statistical analysis, it was proven that mannitol medium, without ethanol, cultured at 20°C 
and at a pH of 5.5 is more optimal for cellulose growth from this bacterial strain.  While cellulose 
production was affected by the factors of carbon source, ethanol addition, and temperature; pH 
alone was not significant.  However, the interaction between carbon source and pH did affect 
cellulose growth.  This was attributed to the acidic byproducts produced by the bacteria when 
cultured on glucose media.  Inoculation ratio was not a significant factor nor was it involved in any 
significant factor interactions.  The statistical model was described by a mathematical equation 
which can predict cellulose yields given a set of factor values.  These preliminary results have 
determined an advantageous factor coupling for optimized cellulose production by this 
microorganism. 
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Chapter 4 
Analysis of Composites with Varying Amounts of BC-CdHAP 
 
 
 In this study, a series of bacterial cellulose-calcium-deficient hydroxyapatite composites 
were made with varying amounts of CdHAP.  This was accomplished by increasing the number of 
sequential incubations of the BC in aqueous calcium chloride and sodium phosphate dibasic.  
The composites were characterized with X-Ray Diffraction (XRD), Fourier Transform Infrared 
Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), and Electron Dispersive 
Spectroscopy (EDS).  The results of this study were published in the journal Biomaterials [84]. 
 
4.1.  Deposition of varying amounts of CdHAP in bacterial cellulose 
Twenty-four bacterial cellulose pellicles were cultured as described in section 2.1.1.   In 
brief, 24 six centimeter culture dishes were filled with 15 ml of inoculated Schramm-Hestrin 
medium and cultured for 31 days.  The bacterial cellulose was then purified using the protocol in 
section 2.1.2.   
Calcium-deficient hydroxyapatite (CdHAP) was formed in bacterial cellulose (BC) by 
performing alternating incubation cycles with calcium and phosphate solutions [61,83].  An 
incubation cycle is defined as suspending the cellulose pellicle in 100 mM CaCl2 (pH 4.83) under 
agitation in an orbital shaker for 24 h (23°C), rinsing the BC briefly in distilled/deionized water, 
then transferring the pellicle to 60 mM Na2HPO4  (pH 8.36) under agitation for another 24 h 
(23°C).  Six groups of four BC pellicles each were synthesized with zero, one, two, three, four, 
and five incubation cycles.  The group with no incubation cycles (native cellulose) was used as a 
control.  
Four replicates of each sample were made so that they could later be dried and weighed 
to determine the amount of CdHAP in each composite.  It was assumed that approximately the 
same amount of cellulose existed in all the composites since they were synthesized under 
identical conditions.  The mass of the CdHAP in the cellulose was determined by subtracting the 
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total composite weight from the average weight of the control cellulose group.  CdHAP weight 
percentages were calculated by dividing the mass of the CdHAP by the total composite weight.   
A homogenous white precipitate immediately formed throughout the bacterial cellulose 
matrix when it was placed the phosphate solution after incubation in aqueous calcium chloride.  A 
picture of a cellulose pellicle that underwent three incubation cycles in 100 mM CaCl2 and 60 mM  
Na2HPO4 compared to unaltered native bacterial cellulose is shown in Figure 4.1.   
Three of each of the composites made according to the conditions in Table 2.4 were 
placed on a gel-dryer (Drygel Jr., Model SE540, Hoefer Scientific Instruments: San Francisco, 
CA, U.S.A.) for 30 minutes at 80°C with application of a 68 kPa vacuum.  The dry weight of each 
sample was measured on a Mettler AE200 electronic analytical balance (Mettler-Toledo: Toledo, 
OH, U.S.A) and recorded in milligrams.  It was assumed that approximately the same amount of 
cellulose existed in all the composites since they were synthesized under identical conditions.  
The mass of the CdHAP in the cellulose was determined by subtracting the total composite 
weight from the average weight of the control cellulose group.    
 
 
Figure 4.1:  Comparison of unaltered bacterial cellulose (left) and cellulose after three incubation 
cycles in 100 mM CaCl2 and 60 mM Na2HPO4 (right) 
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CdHAP weight percentages were calculated by dividing the mass of the CdHAP by the 
total composite weight.   The dry weight of the composites and the mass of their respective 
hydroxyapatite components are shown in Figure 4.2.  The composites appear to linearly increase 
in weight with the number of incubation cycles.  The hydroxyapatite weight percentage of each 
composite is also shown in Figure 4.2.  These weight percentages will be used to distinguish the 
composites. 
 
4.2.  X-Ray Diffraction 
The X-Ray Diffraction patterns of the bacterial cellulose (BC) and cellulose composites 
(BC-HAP) are given in Figure 4.3.  The control bacterial cellulose was identified as native 
cellulose (PDF#03-0289) and the characteristic peaks are indexed.  The sharp peaks indicate 
that the cellulose is highly crystalline which has been previously reported [50,63].   
 
 
Figure 4.2:  Mass of composites and hydroxyapatite components synthesized with increasing 
incubation cycles.  Standard deviations were propagated to obtain error bars [84]   
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 Figure 4.3:  X-ray diffraction patterns of bacterial cellulose (BC) and bacterial cellulose-
hydroxyapatite composites (BC-HAP).  The characteristic HAP peaks are indexed at the top for 
BC-HAP 90% while the characteristic peaks of cellulose are indexed at the bottom [84] 
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The peaks for the BC-HAP composites are identified as calcium-deficient hydroxyapatite 
(CdHAP
ar to the 
cally stable calcium phosphate that exists in 
aqueou
, 
ore 
n, 
rystallite sizes of the composites for each reflection were measured for two 
sample
) (PDF#46-0905).  The CdHAP crystallite peaks are indexed for BC-90%HAP (Figure 
4.3).  The low background of the composites indicates that the CdHAP is crystalline.  The 
decrease in the intensity of the cellulose peaks in the patterns shows that CdHAP is the 
dominating component of the composite.  The XRD pattern of the composite is very simil
XRD pattern of bone apatite (Figure 4.4) [105].   
Hydroxyapatite is the only thermodynami
s solution at a pH greater than 4.2 [35].  Since the cellulose was incubated in solutions 
with pH greater than 4.2 (100 mM CaCl2 at pH 4.83 and 60 mM Na2HPO4 at pH 8.36), 
hydroxyapatite was the expected mineral to form.  As was discussed in the introduction
physiological apatite is almost always calcium deficient compared to stoichiometric 
hydroxyapatite (sHAP) due to contact with a constant flow of trace ions.  CdHAP is m
favorable as a bone implant compared to sHAP due to quicker dissolution, surface modificatio
and bone bonding.   
The CdHAP c
s of each group (Figure 4.5).  The characteristic CdHAP peaks of BC-53%HAP were not 
substantial enough to obtain accurate crystallite dimensions and thus were omitted from Figure  
 
  
Figure 4.4:  X-ray diffraction pattern of bovine cortical bone [adapted from reference 105] 
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 Figure 4.5:  Hydroxyapatite crystallite sizes for various reflections.  Standard deviations were 
propagated to obtain error bars.  The crystallite sizes in the c-axis (002) and (004) are 
significantly larger than those in the a- and b-axes (100), (200), and (300) [84] 
 
4.4.  The crystallites were approximately 10-50 nm.  The crystallite size of CdHAP in the 
composite was comparable to bone apatite crystallites which are 20-40 nm in length [106].  For 
the majority of the plane directions, the crystallite sizes of the composites did not vary significantly 
indicating that the CdHAP crystallites shared the same geometry regardless of the HAP volume 
percentage.  Crystallite sizes amongst composites in the (002), (200), (300), and (111) plane 
directions showed some significant variation as shown in Figure 4.4. 
It was determined that the average crystallite sizes of the (002) and (004) reflections (the 
e crystallites 
consistently shared these dimensions regardless of the mass of CdHAP in the composite.  This 
geometry mimics actual bone apatite crystals which are anisotropic and elongated in the c-axis 
[105]. 
c-direction) were significantly larger than the (100), (200), and (300) reflections (the a and b-
directions).  This indicates that the crystallites were elongated in the c-axis.  Th
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4.3.  Scanning Electron Microscopy and Electron Dispersive Spectroscopy 
Scanning Electron Micrographs of the BC and the BC-HAP composites at various 
magnifications are shown in Figures 4.6, 4.7, and 4.8.  The crystalline lattice composed of fine
cellulose fibrils is seen in Figures 4.7.a and 4.8.a.  In BC-53%HAP, it 
 
is observed that regular 1 
μm hyd
 
ite 
, 
 
images of the BC-53%HAP sample at various magnifications.  Higher magnifications 
gonal crystal 
structur
ite 
roxyapatite clusters had formed within the cellulose fibrils (Figure 4.6.b).  These orderly 
clusters become rough and irregular in shape as more hydroxyapatite is formed in the matrix
(Figures 4.6.c and 4.6.d).  At 1000x, the hydroxyapatite particles in the BC-53%HAP compos
appear as uniform solid spheres (Figure 4.6.b).  At higher magnifications (Figure 4.7.b and 4.8.b)
it is seen the spheres are not solid, but are instead composed of discrete crystallites.  Figure 4.9
shows 
reveal that the clusters are composed of six-sided plates characteristic of the hexa
e of hydroxyapatite (Figures 4.9.c and 4.9.d).   
It has been reported that round “calcospherites” like those seen in the BC-53% compos
mimic that seen during physiological calcification process in the cartilage of human fetal growth  
 
 
Figure 4.6: SEM images of (a) BC, (b) BC-53%HAP, (c) BC-75%HAP, (d) BC-90%HAP at 1000x.  
A 5 kV accelerating voltage was used for all of the samples 
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 Figure 4.7: SEM images of (a) BC, (b) BC-53%HAP, (c) BC-75%HAP, (d) BC-90%HAP at 5000x.  
A 3 kV accelerating voltage was used for the BC sample and a 5 kV was used to image the BC-
HAP composites [84] 
 
 
 
Figure 4.8: SEM images of (a) BC, (b) BC-53%HAP, (c) BC-75%HAP, (d) BC-90%HAP at 
0000x.  A 3 kV accelerating voltage was used for the BC sample and a 5 kV was used to image 
the BC-HAP composites 
 
1
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a) 
V was used to for the 50,000x image [84] 
plates and in woven bone [107].  It has also been claimed that the calcospherite morphology is 
favorable for adhesion and spreading of osteoblasts [107]. 
The Energy Dispersive Spectra of four of the samples are given in Figures 4.10.  The 
calcium to phosphorus ratios varied between 1.46-1.54 demonstrating that the hydroxyapatite is 
calcium deficient.  The ratios did not depend on the weight percentage of the calcium-deficient 
hydroxyapatite.  Traces of sodium and carbon also appear in the spectra.  The Na2HPO4 used 
during mineralizing may have left some sodium residue, while the carbon present is attributed to 
the cellulose. 
 
4.4.  Fourier Transform Infrared Spectroscopy 
The chemical structure of the cellulose chain is shown in Figure 1.6 and the IR spectrum 
s composed of sugar  
Figure 4.9: SEM images of bacterial cellulose-hydroxyapatite composite (BC-53%HAP) at (
1000x, (b) 5000x, (c) 10,000x, (d) 50,000x.  A 5 kV accelerating voltage was used for the 1000x-
10,000x images while 2 k
 
for native bacterial cellulose is given in Figure 4.11.  Each of the IR peaks can be attributed to 
haracteristic chemical groups in the cellulose structure.  Cellulose ic
 56
 
 
Figure 4.10:  Energy Dispersive Spectra of the BC-HAP composites and the respective 
calculated calcium to phosphorus ratios 
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Figure 4.11: IR spectrum of native bacterial cellulose 
 
residues (pyranose rings) connected by glycosidic (C1-O-C4) linkages.  There is also an 
abundance of hydroxyl groups in the cellulose polymer (31.5% of its total weight).  The 
characteristic absorption bands of cellulose are given in Table 4.1. 
The IR spectrum of the composite BC-90% HAP is given in Figure 4.12.  The IR 
spectrum of stoichiometric HAP from Rehman and Bonfield [108] is given in the inset of Figure 
4.12 as a comparison.  It is seen that the cellulose backbone is hardly distinguishable indicating 
that hydroxyapatite is the dominant component in the composite.  The characteristic IR 
absorption bands of hydroxyapatite corresponding to phosphate and hydroxyl vibrational modes 
are identified in Table 4.2.   
Phosphate has four phosphate vibrational modes: ν1 is the symmetric stretching mode, ν2 
 the symmetric bending mode, ν3 is the antisymmetric stretching mode, and ν4 is the out-of- 
et of the ν4 phosphate vibrational mode gives 
is
plane bending mode [109].  The unique doubl
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Table 4.1:  Characteristic bands of native bacterial cellulose 
 
Frequency Relative Intensity Assignment Ref 
3350 cm-1 Strong OH Stretching (involved in intermolecular 
hydrogen bonding) 
[110] 
3240 cm-1 Medium OH Stretching (characteristic of hydrogen 
bonding in cellulose Iα structure) 
[110] 
2900 cm-1 Medium CH Stretching [111] 
2853 cm-1 Medium CH2 Symmetric Stretching [111] 
1653 cm-1  Absorbed H2O [111] 
1435 cm-1 Medium CH2 Symmetric Bending [111] 
1375 cm-1 Medium CH Bending [111] 
1358 cm-1 Medium CH Bending [111] 
1335 cm-1 Medium OH in-plane bending [111] 
1165 cm-1 Strong Antisymmetric bridge COC stretching [111] 
1111 cm-1 Strong Antisymmetric in-phase ring stretching [111] 
1063 cm-1 Strong Skeletal vibrations involving C-O stretching [111] 
1035 cm-1 Strong Skeletal vibrations involving C-O stretching [111] 
1015 cm-1 Medium Skeletal vibrations involving C-O stretching [111] 
895 cm-1 Weak Antisymmetric out-of-phase ring stretching [111] 
663 cm-1 Medium OH out-of-plane bending [111] 
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Figure 4.12: IR spectrum of hydroxyapatite cellulose (BC-90% HAP).  Inset: IR spectrum of 
commercial stoichiometric hydroxyapatite powder [image taken from reference 108] 
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Table 4.2: Characteristic IR bands of calcium-deficient hydroxyapatite  
 
Frequency Relative Intensity Assignment Ref 
3567 cm-1 Strong OH Stretching [108] 
3400 cm  Broad [108] -1 Absorbed H2O  
1653 cm-1  Absorbed H2O [111] 
1093 cm  Very Strong ode [108] -1 Phosphate (PO4-3) v3 vibrational m
1032 cm-1 Very Strong 4 ) v3 vibrational mode Phosphate (PO -3 [108] 
962 cm-1 Medium Phosphate (PO4-3) v1 vibrational mode [108] 
864 cm-1 Weak phate (HPO4-2) vibrational mode Hydrogen Phos [112] 
601 cm-1 Very Strong tional mode Phosphate (PO4-3) v4 vibra [108] 
563 cm-1 Very Strong O4 ) v4 vibrational mode Phosphate (P -3 [108] 
 
i bout the HAP formation an he presence of the 
H t 86 nd the decreas in 
c to the HAP p icates
t site co alcium-defic
The IR spectra of the BC and BC-HAP composites are given in Figure 4.13.  The 
absorbances of the phosphate peaks were graphed against the weight percent of hydroxyapatite 
in the composite (Figure 4.14).  The absorbances were normalized by dividing the phosphate 
absorbance by the cellulose CH peak absorbance at 2905 cm-1.  This peak was chosen because 
its absorbance remains constant in all the samples since the amount of cellulose in the composite 
stays the same.  This rise in absorbance correlates to the increased of concentration of 
hydroxyapatite as dictated by the Beer-Lambert Law.  While the intensity of all the phosphate 
absorption bands increase with the concentration of HAP, the absorbance corresponding to the ν3 
modes exhibit more scatter than those corresponding to the ν1 and ν4 vibrational modes.  The 
variation in the ν3 modes may be attributed to the antisymmetric stretching of the dipole.  
Variation in band absorbance may also be due to small differences in the amount of material in  
the KBr pellets. 
 
4.4.1.  Deconvolution of the Hydroxyl Absorption Band 
ars 
his 
nformation a d will be discussed in a later section.  T
PO4 band a 4 cm  a-1 e in the hydroxyl band intensity at 864 cm-1 (
omparison  stoichiometric owder in given in the inset of Figure 4.12) ind  that 
his compo nsists of c ient hydroxyapatite [108,112]. 
Even though the samples were dried in a vacuum oven at 100°C, a broad peak appe
at 3400 cm-1 in the CdHAP IR spectra which is attributed to water absorption [108].  T
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Figure 4.13: IR s
composites (BC-HAP) [84]
pectra of bacterial cellulose (BC) and bacterial cellulose-hydroxyapatite 
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Figure 4.14: Graph of phosphate peak absorbance versus weight percent of hydroxyapatite 
 
 
suggests that hydroxyapatite binds water.  The diffuse peak dominates the spectra from 3600-
3100 cm-1 hindering the observance of the cellulose hydroxyl stretching bands at 3350 and 3240 
cm-1.  To observe how the presence of the CdHAP phase affected the cellulose hydroxyl groups, 
these absorption bands were investigated by spectral deconvolution.  The deconvoluted bands of 
BC and BC-HAP composites are shown in Figure 4.15-4.20.  It was observed that the cellulose 
hydroxyl groups shifted to lower wavenumbers in the presence of hydroxyapatite.  The precise 
wavenumber shifts of the 3350 cm-1 and 3240 cm-1 hydroxyl IR bands from the original cellulose  
conformation are shown in Figures 4.15-4.20 as red and blue arrows respectively.  For the BC-
90%HAP composite, the hydroxyl absorption band at 3350 cm-1 shifted downwards 106 cm-1 
cm  shifted downwards 155 cm .    
Infrared spectroscopy is capable of distinguishing between a free and hydrogen bonded 
ydroxyl group.  As characteristic infrared absorption bands shift to lower wavenumbers, it 
dicates the possible formation of a new chemical bond with another molecule [95].  In the case 
while the OH absorption band at 3240 -1 -1
h
in
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Figure 4.15:  Deconvoluted IR spectrum of native cellulose  
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Figure 4.16:  Deconvoluted IR spectrum of BC-53% HAP 
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Figure 4.17:  Deconvoluted IR spectrum of BC-75% HAP 
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Figure 4.18:  Deconvoluted IR spectrum of BC-84% HAP 
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Figure 4.19:  Deconvoluted IR spectrum of BC-88% HAP 
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Figure 4.20:  Deconvoluted IR spectrum of BC-90% HAP 
18 cm-18 cm-1
8 cm-1 22 cm-1
of the BC-HAP composites, cellulose hydroxyl groups involved with intramolecular hydrogen 
bonding shifted to lower wavenumbers suggesting that the OH groups are bonding with the 
apatite.  The formation of a chemical bond between the CdHAP and the BC stabilizes the 
composite so that it can maintain the mechanical integrity necessary for bone substitution.  If 
implanted in the body, chemical bonding would prevent the tiny CdHAP particles from being 
released to surrounding tissues and initiating dystrophic calcification [113].  By having a 
distribution of CdHAP bonded throughout the BC, the polymer matrix transfers the stresses to the 
apatite component in such a way that the particles can bear the load [114].   
Previous studies have claimed that functional groups such as hydroxyl and carboxyl 
groups initiate the nucleation of calcium phosphate [115,116].  Dobbins et al. claimed that calcium 
bonds to cellulose more firmly than water solvent m s through specific bonding to carboxyl 
and/or cis-hydroxyl groups [117].  Hartgerink et al. stated that materials with repetitive patterns of 
to nucleate oriented crystals in-vivo 
18].  The hydroxyl groups of the cellulose have a strong negative dipole which could chelate 
free Ca2+ cations in the CaCl2 solution and form a coordinated bond.  Phosphate ions may then 
bond with the cellulose-associated calcium to form calcium phosphate. 
 
4.4.2.  Octacalcium Precursor of Calcium-Deficient Hydroxyapatite 
The IR spectra offer additional information about how the hydroxyapatite was formed in 
the cellulose matrix.  Hydroxyapatite formation from metastable aqueous solutions is usually 
preceded by a precursor phase, most commonly amorphous calcium phosphate (ACP) 
(Ca2(PO4)3) or octacalcium phosphate (OCP) (Ca8H2(PO4)6).  The precursor calcium phosphate 
then hydrolyzes into the more thermodynamically stable hydroxyapatite.  The precursor phase 
depends on the conditions present in the solution during the precipitation reaction [119].  The 
presence of the ν4 PO43- doublet at 602 and 567 cm-1 in all the composites strongly suggests that 
the precursor phase of the hydroxyapatite was octacalcium phosphate [119].  During OCP 
 combining with phosphate.  By 
olecule
anionic groups concentrate inorganic cations and proceed 
[1
formation, Ca2+ first complexes with another species before
 66
organizing the calcium cations onto a matrix prior to mineralization, the OCP precursor ensure
more crystalline and ordered hydroxyapatite phase [119].  If the precursor had been ACP, th
PO43- bands would be a broad singlet instead of a doublet [120].  ACP precipitation usually
requires the rapid interaction between Ca2+and PO43- at high supersaturation instead of precur
complexation with other species.  This precludes the spatial ordering of the ions into a crystal
lattice resulting in a poorly crystalline (though not amorphous) mineral [120]. 
The two main theories of bone mineralization are extracellular nucleation of apatite 
crystals onto type I collagen fibers or the release of precursor apatite crystals
s a 
ese 
 
sor 
 
 formed within 
matrix v oup 
 
 
lyzes into a crystalline 
hydroxyapatite phase which is confirmed by the low background and sharp peaks of the XRD 
e cellulose mimics the 
biomine
 
roxyl 
esicles [121].  In both cases, the calcium first associates with a matrix (a functional gr
in collagen or the matrix vesicle) before forming the calcium phosphate precursor.  OCP has been 
found to be the precursor calcium phosphate phase in an in-vitro study of matrix vesicle formation 
of apatite [119].  In this study, the calcium ions first may first be complexing with the cellulose.  
This fact is supported by the other IR results which suggested chemical bonding between the 
apatite and the cellulose hydroxyl groups.  The ordered arrangement and negative dipole of the
hydroxyl groups in the crystalline BC matrix provides a structured template for the nucleation and
formation of the OCP.  The thermodynamically unstable OCP then hydro
pattern.  By having an OCP precursor, the formation of CdHAP in th
ralization of physiological bone.   
 
4.5.  Conclusion 
It was demonstrated that bacterial cellulose (BC) provides a template for the ordered 
formation of calcium-deficient hydroxyapatite (CdHAP).  SEM showed that ~1 μm CdHAP 
spherical clusters composed of nanosized crystallites had formed within the BC network.  XRD
demonstrated that the CdHAP is comprised of anisotropic 10-50 nm crystallites which are 
elongated in the c-axis mimicking the size and geometry of bone apatite crystals.  FTIR 
spectroscopy strongly suggests that the CdHAP is bonding with the BC via the cellulose hyd
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groups and that it is highly likely the CdHAP had an octacalcium precursor similar to natural bone 
apatite.  The formation of this composite is similar to the physiological biomineralization of bone 
producing apatite crystals of comparable shape and size.  Previous studies suggest that the
presence of CdHAP in this composite will induce bone colonization when implanted into hard 
tissue defects.  Since CdHAP implants rapidly incorporate into the bone tissue, the need for a 
second surgery would be eliminated.  The bioactivity of the calcium-deficient h
 
ydroxyapatite and 
the bioc ntial 
 
ompatibility of the bacterial cellulose hydrogel substantiates this composite as a pote
orthopedic biomaterial. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 68
Chapter 5 
Analysis of Oxidized BC and Oxidized BC-CdHAP 
 
 
The samples were mea
 In this section, bacterial cellulose (BC) was chemically modified via periodate oxidation to 
render the material degradable in mammalian systems.  Oxidized BC and oxidized BC 
mineralized with calcium-deficient hydroxyapatite (CdHAP) were synthesized, characterized, and 
compared to native BC and native BC-CdHAP.  The degradation properties were then analyzed 
by incubating the samples in HEPES buffer (pH 7.4) at 37°C under static and dynamic conditions.  
sured for weight loss while the buffer was analyzed for degradation 
products.  The results of this study will be submitted to the journal Biomaterials [122].  A patent 
application has also been filed for this technology.   
 
5.1   Synthesis of Samples  
 Two batches of bacterial cellulose were cultured as described in section 2.1.1 and 2.1.2.  
Six centimeter pellicles which were ~3 mm thick were produced by culturing the bacteria for 30 
days.  Forty-four pellicles were produced for the first batch.  Half of these samples were oxidized 
using sodium periodate in n-propanol using the protocol in section 2.1.3.  Eleven native BC 
samples and eleven oxidized BC samples were mineralized with CdHAP as given in section 
2.1.4.  In all, four groups of eleven samples were made: native BC, oxidized BC, native BC-
CdHAP, and oxidized BC-CdHAP.  The second batch consisted of the same four groups with six 
samples produced for each to be used for the second in-vitro degradation experiment. 
ate oxidation is a preferred technique since it can be performed on crystalline 
bacterial cellulose and reacts in a specific and predictable manner [68].  The most significant side 
reaction is the production of free radicals during oxidation that can cause non-specific chain 
breakages.  This can be mitigated against by addition of n-propanol as a free-radical scavenger 
during the reaction.  After periodate oxidation with n-propanol, there was no visible change in the 
morphology of the cellulose pellicles when compared to unaltered native bacterial cellulose.  The 
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absence of this reagent resulted in gross c  bacterial cellulose structure and resulted 
 a three-fo
fter incubating the oxidized BC in aqueous calcium and phosphate solutions, it turned from clear 
to a white color indicating mineralization. 
The samples were weighed in hydrated and dried states (Figure 5.1).  The first indication 
that oxidation resulted in changes to the structure of the cellulose was that the wet weight of the 
oxidized BC was significantly less than native BC (Figure 5.1a). In contrast, their dry weights 
were not significantly different (Figure 5.1b).  This data indicates that periodate oxidation did not 
degrade the cellulose network, but the molecular structure undergoes a change that 
compromises its ability to retain water.  It is likely that alteration in the hydrogen bonding pattern 
and network structure due to the formation of aldehyde groups is responsible for its lower affinity 
for water.  Both native and oxidized bacterial cellulose pellicles formed hydroxyapatite within their 
porous ructure after sequential incubation in sodium hydrogen phosphate and calcium chloride 
solutions.  Interestingly, after drying and weighing the samples, it was observed that more CdHAP 
formed in the native BC (62% CdHAP) compared to the oxidized BC (55% CdHAP) (Figure 5.1b).  
This supports the view that alteration in the network structure of the cellulose due to oxidation 
imposes some restriction on the access of the calcium and phosphate salts and results in 
decreased hydroxyapatite formation.  It is also possible that the oxidation of hydroxyl to aldehyde  
 
hanges to the
in ld decrease in the volume of the hydrogels (data not shown).  
A
st
 
Figure 5.1:  Comparison of (a) wet weights and (b) dry weights of native BC, oxidized BC, native 
BC-CdHAP, and oxidized BC-CdHAP [122] 
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groups affects apatite nucleation. 
 
5.2.  Fourier Transform Infrared Spectroscopy  
The FTIR spectra of native and oxidized BC are shown in Figure 5.2.  In the oxidized BC 
spectru
h 
 
verts BC 
 
m, an absorption band appears at 1740 cm-1 that corresponds to the aldehyde carbonyl 
group introduced during peroidate oxidation (Figure 5.2b). A band at 1652 cm-1 that represents 
carbonyl groups involved in hydrogen bonding is present along with a band at 1530 cm-1 whic
most likely corresponds to conjugated aldehyde groups (Figure 5.2b).  The native BC spectrum is
devoid of these absorption bands (Figure 5d), confirming that periodate oxidation con
into dialdehyde cellulose.  After depositing CdHAP into the oxidized BC, the carbonyl absorption 
bands shift to lower wavenumbers (Figure 5.2a) indicating the formation of a new chemical bond 
with another molecule [95].  It is likely that the negative dipoles of the cellulose aldehyde groups 
bond to the calcium cations of the CdHAP mineral.  A shift in the hydroxyl groups of the oxidized  
 
 
Figure 5.2: FTIR spectra of (a) oxidized BC-CdHAP, (b) oxidized BC, (c) native BC-CdHAP, and 
(d) native BC [122] 
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cellulose was not observed indicating the apatite was interacting predominantly with the aldheyde 
roups.  Having the CdHAP particles chemically bound to the oxidized BC ensures that the 
lso prevents the CdHAP particles from being 
release  
) 
g
composite will stay conjunct upon implantation.  It a
d which could cause damage to the surrounding tissues and nitiate dystrophic calcification 
[113].      
 
5.3.  X-Ray Diffraction  
X-ray diffraction was performed on the dried native and oxidized materials to determine 
how the oxidation reactions affected the crystallinity of the materials. The x-ray diffraction (XRD
pattern of BC (Figure 5.3a) showed the typical crystalline structure of native cellulose (PDF#03-
0289) as defined by sharp defined peaks at 14.7 and 23.1° 2θ.  Treatment of cellulose with 50 
mM periodate for 24 hours at 23°C did not appreciably disrupt the crystalline structure of BC  
 
 
Figure 5.3: X-ray diffraction patterns of (a) native BC, (b) oxidized BC, (c) native BC-CdHAP, and 
(d) oxidized BC-CdHAP [122] 
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(Figure 5.3b).  In addition XRD confirmed that the oxidized material formed CdHAP after 
sequential incubation in calcium and phosphate solutions (PDF#46-0905) (Figure 5.3c).  
Therefore we can conclude that the oxidized cellulose forms CdHAP with a similar pattern to that 
formed in native cellulose (Figure 5.3d).   
 
5.4.  Scanning Electron Microscopy 
e samples are shown in Figure 5.4.  The fine fibrils of native BC are 
seen in
SEM images of th
 Figure 6a.  The oxidized BC had a similar morphology (Figure 5.4b) showing that the 
oxidation did not disrupt the structure of the polymer.  In the native BC-CdHAP sample, it is 
observed that regular 1 μm hydroxyapatite clusters had formed within the cellulose fibrils 
composed of discrete needle and plate-like crystallites (Figure 5.4c).  The oxidized BC-CdHAP 
sample also contained spherical 1 μm clusters with a similar morphology (Figure 5.4d).  The  
 
 
Figure 5.4: SEM images of (a) native BC, (b) native BC-CdHAP, (c) oxidized BC, and (d) 
oxidized BC-CdHAP [122] 
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previous chapter confirmed that the CdHAP formed in native BC had similar size, shape, 
morphology, and chemistry to natural apatite found in bone.  As discussed in the previous
chapter, “calcospherites” like those seen here have also been observed during natural bone 
calcification and are favorable for the adhe
 
sion and spreading of osteoblasts [107]. 
t 
d 
les 
s 
.  
However, presence of the CdHAP in both the native and oxidized cellulose causes an 
approximate 50% decrease in ultimate tensile strength.  Formation of the CdHAP crystallites  
 
 
5.5.   Mechanical Testing  
The mechanical tensile properties of the oxidized and native materials, with and withou
hydroxyapaptite, were determined to establish the relationship between chemical alteration an
the resulting physical properties.  The engineering stress-strain curves of the hydrated samp
are shown in Figure 5.5.  The ultimate tensile strength and elastic modulus values were 
calculated from these curves and are compared in Figure 5.6.  The data show that oxidation doe
not appreciably affect the ultimate tensile strength or elastic modulus of the bacterial cellulose
 
Figure 5.5: Engineering stress-strain curve of (a) native BC, (b) oxidized BC, (c) native BC-
CdHAP, and (d) oxidized BC-CdHAP [122] 
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 Figure 5.6:  Comparison of (a) ultimate tensile strengths and (b) elastic moduli of native BC, 
 
which are bonded to the cellulose hydroxyl and/or aldehyde groups may interrupt the natural 
hydrogen bonding and weaken the mechanical properties.  Presence of CdHAP imparted 
brittleness in both the native and oxidized BC, causing an approximately 40% increase in elastic 
modulus.   
 The mechanical properties of the BC-CdHAP material correspond to particulate 
composite theory.  The elastic modulus of a particule-reinforced composite increases with filler 
content [42].  Addition of the particulate filler decreases strength in tension and increases strength 
in compression.  As is evident in Figure 5.6, adding the CdHAP nanoparticles increased the 
elastic modulus and decreased tensile strength in both the native and oxidized BC.  Though not 
carried out, it is expected the compressive strength of the CdHAP composites would be greater 
than the native or oxidized BC. 
 
5.6.  In-Vitro Degradation Testing of the Oxidized Cellulose Samples 
The degradation of the samples were monitored as described in section 2.3.  The first 
batch of samples was incubated in HEPES buffer which was analyzed every other day for 
degradation products using UV-Visible spectroscopy.  At the end of the study, the samples were 
oxidized BC, native BC-CdHAP, and oxidized BC-CdHAP [122] 
 
rinsed, dried, and weighed.  The second batch of samples remained in the same volume of 
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HEPES buffer throughout the study.   At the end of the study, the buffer was assayed for free 
carbohydrate and glycolic acid. 
 
5.6.1.  Weight Loss of Samples 
After placing the samples in a simulated aqueous physiological environment at pH 7.4 
and 37°C for 14 days under static and dynamic conditions, the oxidized BC lost significant mass 
compared to the native material (Figure 5.7).  An average, the dry mass of oxidized BC was 
reduced by 38% and 36% after static and dynamic incubation respectively.  In contrast, the native  
ubated under the same 
onditions, but the loss was not statistically significant.  The fact that weight loss was similar in 
the samples that underwent static and dynamic incubation indicates that the degradation of 
periodate oxidized cellulose is not due to physical disruption during agitation, but is a result of the 
action of the simulated physiological buffer on the material.  
Oxidized BC-CdHAP only lost significant weight after dynamic incubation in the HEPES 
buffer at 37°C, losing 23% of its mass on average.  Mechanical disruption therefore did affect the 
mass loss of the oxidized BC-CdHAP composite.  The chemical bonding between the oxidized  
 
material was decreased by an average of 8% and 20% when inc
c
 
Figure 5.7: Comparison of sample masses before and after incubation in low salt HEPES buffer 
(pH 7.4) at 37°C in static and dynamic conditions [122] 
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cellulose and CdHAP may not be as strong as that between the native cellulose and apatite, 
causing some of the CdHAP particles to detach when it is continuously agitated.   
 
 UV-Visible Spectroscopy 
 
t of 
g 
l 
orbance peak at 260 nm as a result 
of ultrav
determi  if cellulooligosaccharides absorb in this region.  A bacterial cellulose sample was 
homogenized in water using a commercial blender and after centrifugation of the resulting 
suspension, a peak at 260 nm was observed in the supernatant.  This indicates that mechanical 
disruption releases cellulose fragments which absorb at 260 nm. 
Representative spectra of the oxidized and native BC HEPES supernatant after 4 days 
are shown in Figure 5.8.  It can be seen that the native material releases a small amount of 
material with a peak at 260nm, whereas the oxidized BC has peaks at both 240 and 260nm. This 
indicates that the oxidized cellulose releases cellulooligosaccharides (260 nm) and carbonyl 
containing species (240 nm) which are most likely glycolic acid and/or 2,4-dihydroxybutyric acid.  
Conversely, native cellulose does not break down into carbonyl products and only releases 
5.6.2.  Measuring Degradation by
It was of interest to identify and quantify the degradation products that are released from
the cellulose hydrogels by incubation in simulated physiological buffer.  The main components 
expected were carbohydrate, glycolic acid and 2,4-dihydroxybutyric acid.  Direct measuremen
cellulose degradation products by UV-visible spectrophotometry was carried out.   
A previous investigation demonstrated that an absorption band appeared at 240 nm durin
degradation of plant cellulose powder.  This band was assigned to the n-π* transition of carbony
groups [123].  Both glycolic acid and 2,4-dihydroxybutyric acid, as well as intermediate 
degradation products contain carbonyl groups which absorb in this region [123].  In addition, 
previous cellulose degradation studies have observed an abs
iolet photolytic degradation [124], enzymatic hydrolysis [125], and acid hydrolysis [126].  
This peak was assigned to a weak chromophore associated with acetal groups, which form the 
linkages between glucose residues in cellulose [127].  An experiment was conducted to 
ne
soluble cellulose fragments (260 nm).   
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 Figure 5.8: UV-Vis spectrum of HEPES supernatant from (a) oxidized BC after 4 day dynamic
incubation at 37°C (b) native BC after 4 day dynamic incubation at 37°C
 
The absorption spectra of the fluid surrounding the oxidized and native cellulose samples
under static conditions were recorded at intervals during the degradation study.  The absorbance
versus time plots are given for the static samples at 240 nm (Figure 5.9), static samples at 260
(Figure 5.10), dynamic samples at 240 nm (Figure 5.11), and dynamic samples at 260 nm (Fig
5.12).    Oxidized BC released a high concentration of degradation products that absorbed a
nm and 260 nm during the early time periods which eventually decayed to an equilibrium value.  
The degradation products are most likely carbonyl species and ce
 
 
 
 
 nm  
ure 
t 240 
llulooligosaccharides.  Oxidized 
BC-CdH d 
cts 
.  
AP also released these products in a similar manner, though not as much as the oxidize
BC alone.  Native BC and native BC-CdHAP did not release any carbonyl degradation produ
and only a small amount of soluble carbohydrate was detected.  This supports the gravimetric 
analysis on these samples.  The graphs were similar under both static and shaken conditions
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Figure 5.9:  Absorbance versus time of HEPES supernatant of static samples at 240 nm. ♦ - 
xidized BC, ■ - oxidized BC-CdHAP, ● - native BC-CdHAP, ▲- native BC [122] 
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igure 5.10: Absorbance versus time of HEPES supernatant of static samples at 260 nm. ♦ - 
oxidized BC, ■ - oxidized BC-CdHAP, ● - native BC-CdHAP, ▲- native BC [122] 
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Figure 5.11: Absorbance versus time of HEPES supernatant of dynamic samples at 240 nm. 
oxidized BC, ■ - oxidized BC-CdHAP, ● - native BC-CdHAP, ▲- native BC 
♦ - 
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Figure 5.12:  Absorbance versus time of HEPES supernatant of dynamic samples at 260 nm. 
oxidized BC, ■ - oxidized BC-CdHAP, ● - native BC-CdHAP, ▲- native BC 
♦ - 
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5.6.3.  Identification of Degradation Products 
The HEPES supernatant was assayed for free carbohydrate and glycolic acid as 
described in section 2.3.1.  One assay used anthrone in concentrated sulfuric acid to detect free 
carbohydrate [77].  Although the results showed that all of the samples released free 
carbohydrate, the variance between samples was too high to accurately quantify the amount of 
carbohydrate released (Figure 5.13).   
Dihydroxynaphthalene has been reported to preferentially react with glycolic acid [128] 
and has been used to in previous degradation studies of dialdehyde cellulose [77,78].  As 
reported in several papers, glycolic acid is an expected byproduct of dialdehyde cellulose 
hydrolysis [77,78].  The characteristic violet color was observed after reacting 2,7-
dihydroxynaphthalene with the supernatants of the oxidized cellulose samples (Figure 5.14). 
However, a similar color change was also observed in the native cellulose samples (Figure 5.14).  
esence of 
concentrated sulfuric acid [128].  The formaldehyde then reacts with the 2,7-
dihydroxynaphthalene and produces a violet color [128].  It was determined that this 2,7- 
 
In this reaction, formaldehyde is released from glycolic acid in the pr
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Figure 5.13:  Results of free carbohydrate assay using anthrone in concentrated sulfuric acid  
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Figure 5.14:  Results of glycolic acid assay using 2,7-dihydroxynaphthalene in concentrated 
sulfuric 
 
dihydroxynaphthalene reacts strongly with glucose in the presence of concentrated sulfuric acid 
in this study (data not shown).  Correspondingly, aldehyde groups on the cellulose reducing ends 
that were hydrolyzed by the concentrated sulfuric acid most probably react in the same manner.    
Additionally, it has also been published that other aldehydes react similarly with 2,7-
dihydroxynaphthalene [128].  In conclusion, this assay is not specific for glycolic acid detection 
since it reacts positively with free cellulose and glucose in the supernatant.  Alternative tests must 
be carried out to confirm whether glycolic acid was released from the samples. 
 
5.7.  Conclusion   
The aim of this study was to chemically alter BC so that it would safely resorb when 
implanted in-vivo.  The modification had to preserve the structural properties of the BC and retain 
its ability to biomimetically form CdHAP nanocrystallites when incubated in calcium and 
phosphate solutions.   
acid  
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Periodate oxidation is a preferred technique since it can be performed on crystalline 
bacterial cellulose, reacts in a specific and predictable manner, and is devoid of significant side 
reactions [68].  To ensure that the periodate oxidation would not degrade or disrupt the native 
structure of BC, a free-radical scavenger (n-propanol) was added.  After periodate oxidation with 
n-propanol, there was no apparent change in the cellulose structure when compared to unaltered 
native bacterial cellulose.  BC oxidized by periodate retains the ability to initiate the mineralization 
of CdHAP which is chemically bonded to the polymer via its carbonyl functional groups.  The 
CdHAP produced in oxidized BC is similar in morphology and chemistry to that produced in native 
BC which has been previously shown to be similar to natural bone apatite.  
It was shown that periodate oxidized BC and BC-CdHAP degrades in a simulated 
aqueous physiological environment.  In-vitro degradation in HEPES buffer (pH 7.4) under static 
and dynamic conditions at 37°C caused the oxidized BC and oxidized BC-CdHAP to significantly 
ough it was attempted to identify and quantify the degradation products released 
ia colorimetric analysis, it was determined that the assays selected were not sufficient for this 
d 
 
lose mass.  Th
v
system.  UV-Vis spectrophotometry was a better method to measure the release of degradation 
products which are most likely small cellulose fragments, glycolic acid, or 2,4-dihydroxybutyric 
acid.  Bioactive CdHAP has been proven to regenerate bone when implanted into osseous 
defects and subsequently degrades.  By immobilizing nanocrystallites of CdHAP into oxidize
cellulose, the entire composite has the capacity to eventually be resorbed and replaced by natural 
bone.  
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Chapter 6 
Clinical Applications of BC-CdHAP Composite 
 
 
It has been shown that the calcium-deficient hydroxyapatite component of the bacterial 
Bone grafts are used in various areas of medicine in different areas of the human body.  
It is necessary for the bone graft to have the specific material properties suitable for its particular 
application.  For example, a bone graft used to reconstruct the bone around a hip joint must have 
the proper mechanical properties to bear the patient’s weight, or be used in conjunction with 
another structural appliance.   
cellulose composite mimics the composition, chemistry, and size of physiological apatite giving 
the composite the potential of substituting bone.  However, it is necessary to find the specific 
To accomplish this, the candidate interviewed several surgeons representing the three main 
areas of medicine that utilize bone grafts to gather their input about possible applications for the 
they ultimately select the products which they believe are scientifically sound and are comfortable 
using.  This chapter summarizes these findings and proposes specific bone graft procedures for 
6.1   Bone Graft Procedures 
 A breakdown of bone graft procedures performed in 2004 is given in Figure 6.1.  As is 
rent, bone graft procedures predominantly fall into three main areas of medicine: 
neurosurgery, orthopaedics, and oral / maxillofacial surgery [129].  Neurosurgeons perform spinal 
s which account for almost half of the bone grafting procedures in the U.S. [129].  
aedic surgeons repair severe long bone fractures and bone damaged by artificial joints 
during revision surgery.  Oral and maxillofacial surgeons also utilize bone grafts though not as 
ntly as neurosurgeons or orthopaedic surgeons [129].  The specific bone graft procedures 
ciated with these fields are discussed in the following sections. 
application and bone site for which the material properties of this composite would be suitable.  
BC-CdHAP composite.  Physician input is very important in developing medical devices since 
which this material could be used.   
 
appa
fusion
Orthop
freque
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2% 3% 4%
10%
9%49%
12%
11%
Humeral fractures Radial / Ulnar fractures
Total knee arthroplasty revisions Femoral fractures
Tibial / Fibular fractures Total hip arthroplasty revisions
Oral and maxillofacial surgery Spinal fusions  
Figure 6.1:  Bone graft procedures in the U.S.A., 2004 [129] 
 
6.2.  Neurosurgery 
Spinal fusion is one of the most common forms of spine surgery.  An estimated 380,00
spinal arthrodesis procedures were performed in the U.S. in 2004 [130].  Most spinal fusion is 
performed in the lumbar (lower back) region of the spine, but can also be used to treat cervical
(neck) and thoracic (chest region) problems [131].  Patients who suffer from severe pain or 
neurological deficits may elect spinal fusion surgery to alleviate their symptoms.  The most 
common conditions requiring spinal fusi
0 
 
on are degenerative disc disease, stenosis, scoliosis, 
ndylolisthesis, and trauma [131].   
al techniques to accomplish spinal fusion, but the most common is 
e post d 
ons 
 
Figure 6.2) [132].  
spo
There are many surgic
th erolateral lumbar intertransverse process [132].  In this procedure, the spine is accesse
from the back and the muscle is removed from the transverse processes.  Bone graft is then 
placed between the transverse processes of the vertebrae and muscle is replaced to hold the 
graft in place.  A 10-40% non-union rate has been reported in patients with single-level fusi
using the posterolateral lumbar intertransverse process.  The rate of non-union increases when
multiple fusion levels are attempted [132].  To provide greater support and a better chance of 
fusion, spine surgery instrumentation is implemented.  These include pedicle screws, wires, rods, 
plates, and cages to provide internal fixation between the vertebrae (
 85
 Figure 6.2:  Instrumented posterolateral lumbar intertransverse spinal fusion [image modified 
from http://adam.about.com/encyclopedia/] 
 
 by non-union) has been reported 
sterolateral intertransverse lumbar spinal fusion with internal fixation [132]. 
vide 
rior and interbody fusions simultaneously, termed a 
circumfe
n 
d  
However, a 10-15% pseudarthrosis rate (or movement caused
in patients who had po
Another technique to enhance arthrodesis is to perform a posterior lumbar interbody 
fusion (PLIF).  This entails the complete removal of the intervertebral disc, decortication of the 
vertebral endplates, and insertion of an intervertebral bone graft [133].  Either a bone graft is 
placed alone, or an interbody spacer (made of metal or polyetheretherketone) filled with bone 
graft is inserted into the cleared disc space (Figure 6.3).  Pedicle screws are then used to pro
stability [133]. 
It is also possible to perform poste
rential or 360° fusion.  While this provides a much higher chance of successful fusion, 
circumferential fusions require a longer operating time, greater blood loss, higher cost, and a 
longer hospital stay [133]. 
As with most current bone grafting procedures, autograft bone remains the most commo
graft type used in spinal fusion procedures.  However, the increased postoperative pain and cost 
that autografts add to spinal procedures creates a demand for bone graft substitutes [133].  
Allograft and demineralized bone are also commonly used in spinal fusion, but carry risk of 
immunogenic response and disease transmission, and have decreased osteogenic potential and 
strength due to processing [133].  Alloplasts such as hydroxyapatite, tricalcium phosphate, an
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 Figure 6.3:  Interbody spinal fusion using a titanium cage filled with bone graft [image modified 
om http://adam.about.com/encyclopedia/] 
 
coral derivatives relieve the hazards of disease transmission and immune response.  However, 
they produce much lower fusion rates when used alone in comparison to autograft and allograft 
[133].   
 
6.2.1.  BC-CdHAP for Spinal Fusion  
 Neurosurgeons were presented with samples of the BC-CdHAP and subsequently 
surveyed.  The surgeons indicated that they liked the morphology, feel, and handling properties of 
the BC-CdHAP membrane.  They stated that they liked working with flexible membranes which 
could easily be cut and shaped for specific defect sites.  They are much easier to handle than 
synthetic grafts that come in a powder, morsel, or putty form.  An Implant Technician and Planner 
from a hospital operating room stated that neurosurgeons prefer a flexible sheet form for bone 
grafts as it gives doctors more options for application.  A common practice is to roll the flexible 
membrane into a “cigar” and insert it into the cavity or gap.  The technician also believed that 
since the BC-CdHAP can be used straight out of the package, it is much more user friendly in 
comparison with other products which must be mixed or combined right before application.  The 
Infuse® product comes in two components and cannot be implanted until a precise time after 
mixing.  As mentioned, interbody cages are commonly used in spinal fusion procedures which are 
fr
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filled with the bone graft.  Thus, the regenerative properties of the BC-CdHAP could easily be 
packed into the cages which would provide structural support.   It was also commented that if the 
BC-CdHAP could be cost-effectively produced, a lower price would be a major incentive for many 
surgeons and hospitals to use this material. 
A highly competitive bone graft currently on the market is called Infuse® (Medtronic: 
Minneapolis, MN, U.S.A.).  This product utilizes biologic growth factors to stimulate rapid bone 
growth.    Infuse® features recombinant human bone morphogenetic protein 2 (rhBMP-2) in a 
bovine Type I collagen sponge carrier.   
his discourages many hospitals and physicians from using Infuse® since insurance cannot cover 
onge at least one half hour, but no more than 2 hours, prior to implantation.   
BC-CdHAP may be an efficient delivery system to BMP-2 since proteins readily bind to 
the BC-CdHAP could release BMP-2 in an efficient 
anner ly, if 
, 
While this product has found great success in spinal fusion, BMP-2 is very expensive.  
T
its cost.  Other difficulties arise in the preparation and delivery of this product.  Infuse® comes in 
two components, the collagen sponge and a syringe with the rhBMP-2.  The rhBMP-2 must 
injected into the sp
hydroxyapatite via electrostatic interactions.  If 
m , less protein would be needed and the product would be less expensive.  Additional
the protein is preloaded onto the BC-CdHAP, there would be no need to mix the components 
prior to implantation. 
 
6.3.  Orthopaedics 
Orthopaedic surgeons use bone grafts primarily in two areas: repairing severe fractures 
and reconstruction during artificial joint revisions.  As evident in Figure 6.1, fractures requiring 
bone grafts primarily occur in the femur, tibia, and fibula; but also occur in the humerus, radius
and ulna.  A significant number of bone grafting procedures were performed on total hip 
arthroplasty revisions, with a smaller number utilized in total knee arthroplasty revisions (Figure 
6.1).   
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6.3.1.  Fracture Repair 
It has been estimated that 7.9 million fractures occur annually in the United States and 
between 5-10% of these result in delayed or impaired healing [134].  The three main options for 
bone fracture treatment are casting, open reduction followed by internal fixation, and open 
reductio e 
 
lerate fracture healing [134].  In general, bone graft 
substitu
s 
which m
s 
product is an injectable calcium phosphate cement called Norian SRS® 
ynthes: West Chester, PA, U.S.A.) which sets into carbonated apatite which can be remodeled 
5].  Norian SRS® is appropriate for non-weightbearing applications or to 
augmen
The number of revision total hip arthroplasties increased from approximately 24,000 in 
990 to 43,000 in 2002, while the number of revision total knee arthroplasties increased from 
n followed by external fixation.  The latter two procedures require surgery to repair th
fracture via screws, plates, and/or rods under the skin (internal fixation) or placement of an 
external frame (external fixation) to support the bone and keep it in place.  Bone grafts may be
used to ensure proper healing or to acce
tes alone provide no stability to the fracture site and must be used in conjunction with 
internal or external fixation.  They are typically employed early after a fracture if there is a 
significant loss of bone, a considerable gap between the broken ends (non-union), or to prevent 
delayed healing.  
As previously mentioned, autografting and allografting present severe problems and risk
ay be alleviated with the development of efficacious alloplasts.  Various alloplasts have 
been used for bone fracture repair including ceramics (hydroxyapatite, tricalcium phosphate) and 
polymers (polymethylmethacrylate, polyglycolide, poly-L-lactide).  One study found that 
hydroxyapatite performed equally as well as autograft in the treatment of tibial plateau fracture
[136].  Another successful 
(S
into natural bone [13
t fixation devices (33, 135).  It is strongly believed that synthetic scaffolds may be 
developed in conjunction with biologics (BMP, TGF- β) to produce an alloplast with superior 
compressive resistance and comparable osteogenic capacity than that of autograft bone [135].   
 
6.3.2.  Joint Revision Reconstruction 
1
 89
approximately 12,000 in 1990 to 35,000 in 2002 [137].  The large number of failed joint 
replace  
sions, 
0].  
141].  
lk allograft or impaction morselized allograft bone grafting which can be 
supplem
evision 
ments has significantly increased the demand for bone grafts [138].  After the failure of a
primary joint arthroplasty, less bone is available due to stress shielding, osteolysis, loosening, or 
infection [139].  More bone may also be removed during implant removal [139].  During revi
deficient bone stock must be reconstructed to restore proper kinematics and allow component 
fixation [138].   
Bone defects repaired during joint revision surgery are usually quite substantial.  
Autograft bone is uncommon in most revision procedures due to size limitations, donor site 
morbidity, and concerns about bone quality in elderly and postmenopausal female patients [14
Subsequently, allograft is the most common bone graft used in joint revision surgery [139, 
  During revision knee arthroplasty, bone stock in the femur and tibia is typically 
reconstituted by bu
ented by cement or metal augments (Figure 6.4) [141].  During revision hip arthroplasty, 
the acetabular component can be reconstructed using cancellous autograft with hemispheric 
components, grafting of osteolytic defects with cementless cup retention, cancellous allograft with 
acetabular reconstruction cages, and acetabular impaction grafting with cement [140].  R
hip reconstruction of the femoral component can be accomplished via impaction cancellous 
grafting with cementing, grafting around well-fixed components, and grafting of osteolytic lesions  
 
 
Figure 6.4:  Illustration of knee revision arthroplasty reconstruction of femoral component with 
[image modified from http://www.eorthopod.com] 
morselized bone graft (left) and bulk cortical allograft reconstruction of tibial component (right) 
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in the greater trochanter [140].   
Impaction grafting using morselized allograft is a prevalent method in both knee and hip 
revision procedures [142, 143].  An illustration of femoral impaction grafting during hip revision 
from Nellisen et al. is shown in Figure 6.5 [142].  The basic steps of impaction grafting entail the 
removal of the old implant and cement, restriction of the canal by using a bony pedestal or 
cement restrictor, reinforcing the bone wall with screening or wires, impacting cancellous bone 
chips us ion of 
been su eramic 
ls 
 
superio o another [140]. 
 
6.3.3.  BC-CdHAP for Orthopaedic Bone Grafting 
Orthopaedic surgeons surveyed claim that the BC-CdHAP may be used to treat cavitary 
or contained defects during revision surgery.  Significant bone deficiencies found in segmental 
defects, uncontained defects, or pelvic discontinuities typically require structural grafts and/or 
metal augments to ensure proper mechanical stability.  However, the surgeons claimed that a 
variety of grafts perform adequately in contained defects.  Thus, cost is a major factor in selection  
ing a tamper, insertion of cement to incorporate with the bone graft, and implantat
the new stem while the cement is setting [142, 143]. 
Ceramic alloplasts are approved for filling nonweightbearing bone defects in the 
extremities and pelvis, but the efficacy of their use in revision arthroplasty procedures has not 
fficiently studied [140].  There are also concerns about the possible migration of c
grafts into the joint space which could cause third body wear [140].   
A significant drawback in the development of efficacious bone grafts for joint revision 
procedures is insufficient testing and data.  One reason is the lack of appropriate animal mode
to simulate the biologic environment of arthroplasty procedures.  The few studies of bone graft 
incorporation in humans that have been completed were analyzed radiographically.  Radiographic
results do not necessarily correlate with histologic incorporation.  Additionally, there are few 
randomized or comparative studies to determine whether one bone graft option is clinically 
r t
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 Figure 6.5: Steps involved with impaction grafting of proximal femur: (a) insertion of distal cem
bone graft is packed with cannulated tamp, (e) rotation is applied for adequate tamp seating, (f) 
ent 
plug, (b) plug is driven to distal areas of lytic bone, (c) bone graft is placed into femoral canal, (d) 
addition ne graft is packed near proximal line of resection, (g) cement is introduced into 
neomedullary canal, (h) cement is pressured with proximal seal, (i) implant stem is introduced 
and cement is further pressurized with a plate [imaged modified from reference 142] 
al bo
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of grafts for contained defects.  If the BC-CdHAP could be made and sold at a competitive price, 
it would make it an attractive option as an orthopaedic bone graft for contained defects. 
 
6.4.  Oral and Maxillofacial Surgery 
Bone grafts are used in maxillofacial and oral surgery to repair bone defects caused by 
trauma, tumors, congenital defects, infection, and jaw resorption due to edentulism.   Oral 
surgeons were interviewed and described the main bone grafting procedures they perform along 
with the type of graft typically used. 
Patients who have significant bone loss due to cancer and removal of tumors undergo 
bone grafting after disease treatment.  The surgeons stated that they almost exclusively used 
autograft bone for larger defects.  They claim the autogeneous bone produces a quicker, safer, 
and more complete bone restoration than allograft or synthetic grafts.  However, the surgeons are 
more likely to use allografts or alloplasts for smaller defects.  Similar comments were made about 
defects due to trauma: autograft bone for larger defects while allograft and alloplast materials for 
smaller repair sites. 
A common congenital defect that oral/maxillofacial surgeons address is cleft palate.  
Bone grafting is standard treatment for treating patients with facial clefts.  This provides support 
for teeth, lip, nose, premaxilla, and provides improved symmetry of appearance.  Gaps present in 
the alveolus and palate are filled with bone graft.  Autograft is most commonly used, although 
allograft bone is used on occasion. 
The most common bone grafting procedures oral and maxillofacial surgeons entails the 
restoration and preservation of the jaw and alveolar ridge due to tooth loss or periodontal 
disease.  Many times, these procedures are termed “dental bone grafts” since they are conducted 
in preparation of dental implants.  Dental implants are increasingly accepted as a replace ent for m
missing or extracted teeth and offer improved aesthetics and function compared to dentures.  
Dental implants are surgically anchored into the jawbone via titanium screws [14].  The success 
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of the dental implant is dependent on the bone quantity and quality where it is placed.  For that 
reason, grafting is essential to create a strong osseous foundation for dental implantation.  
Patients who must have teeth removed as a result of trauma, periodontal disease, or 
e jaw.  After a tooth is extracted, there is a 25% decrease 
in the w
 
wth (Figure 6.6).  Commonly, allograft bone chips or ceramic 
particle
re 
caries are susceptible to bone loss in th
idth of alveolar bone during the first year.  In the first year following multiple extractions, 
alveolar bone height decreases an average of 4 mm [14].  A procedure that prevents jaw 
resorption after tooth removal is site extraction preservation.  Oral surgeons will fill the socket with
bone graft to stimulate new bone gro
s are used.  To ensure the graft stays in place, the site is typically covered with a 
resorbable membrane (Figure 6.6).  Surgeons surveyed use a variety of grafts for this procedu
including demineralized allograft bone, β-tricalcium phosphate particles, or Bio-Oss® xenograft 
(Osteohealth: Shirley, NY, U.S.A.). 
Patients who have suffered tooth loss without site extraction preservation typically  
 
 
Figure 6.6: Site extraction preservation procedure: (a) tooth is removed, (b) bone graft material is 
placed into the extraction socket, (c) a membrane is often placed over the grafted material, (d) 
sutures are placed into the gum tissue [image modified from http://henryschwartz.tripod.com] 
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develop a defect in the jaw ridge.  One method to repair this is ridge augmentation [14].  During 
this procedure, the bony ridge of the jaw is expanded with metal rods.  The inner spongy 
compon
in 
equire autograft bone obtained from the chin or back of the 
jaw.     
 
ent of the ridge bone is compressed and the outer cortexed is expanded with tapping 
expanders to create a socket.  Bone graft is placed in the socket to stimulate new bone growth 
(Figure 6.7).  Surgeons surveyed typically use autogenous bone from the back of the mandible 
(ramus) or chin for ridge augmentation, or demineralized freeze-dried bone.   
Alternatively, bone can be regenerated on top of the upper jaw with a sinus lift procedure 
(Figure 6.7).  In this technique, a window is created in the maxillary sinus.  The sinus membranes 
are lifted, and the resulting gap is filled with bone graft.  Sinus lifts can also be performed 
conjunction with the placement of dental implants (Figure 6.8).  Surgeons surveyed use 
demineralized freeze-dried bone, β-tricalcium phosphate, or Bio-Oss® xenograft for sinus lift 
procedures.  Larger sinus lifts may r
 
 
Figure 6.7:  Dental bone grafting sites for ridge augmentation and sinus lifts [image taken from 
http://www.americandental.ru] 
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6.4.1.  BC-CdHAP for Dental Bone Grafting 
Direct feedback from oral surgeons indicated that the BC-CdHAP material has ide
material properties for dental bone grafting procedures.  Bone in this area is in close proximity 
soft tissues including gingiva, nerves, and sinus membranes.  Traditional bone grafting materials
including allograft bone chips, xenograft hydroxyapatite particles, or β-tricalcium phosphate 
granules have great potential to damage surrounding soft tissues.  Additionally
al 
to 
 
, these loose grafts 
are pron
 that the bioactive CdHAP is immobilized in the defect site.  This provides direct 
osteoco duction and prevents migration of the CdHAP to surrounding tissues.   
In site extraction preservation procedures, the socket is filled with bone chips and  
 
 
igure 6.8: Sinus lift procedure performed in conjunction with dental implantation [image taken 
om http://www.dr4est.com] 
 
e to leakage and migration. 
The BC-CdHAP material features a flexible and supple membrane than can easily be 
packed into defects of various shapes and sizes.  The CdHAP nanocrystallites are evenly 
dispersed throughout the bacterial cellulose producing a strong flexible sheet with a soft 
nonabrasive surface.  The nanocrystallites also have high surface area which provides active 
sites for bone cell attachment.  Since the particles are chemically bound to the cellulose, this 
ensures
n
F
fr
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ceramic particles.  The socket is then covered with a membrane to keep the graft in place.  The 
flexible 
 
tle ceramic particle bone grafts can puncture this membrane 
up to 60
ible, 
 not 
 
 
 
 
 
 
 
 
 
 
and supple BC-CdHAP material can easily be packed into extraction sites.  The 
nonabrasive CdHAP nanocrystallites will not damage the surrounding gum tissues.  The cellulose
carrier also prevents the CdHAP particles from migrating to neighboring areas.  An extra 
membrane to cover the graft is thus unnecessary. 
During sinus lifts, the delicate Schneidian membrane of the sinus is prone to damage 
[145].  Traditional bone chips and brit
% of the time [145].  The particles can then migrate into the sinus cavity and cause 
complications such as graft contamination, bacterial infection, and sinusitis.  Being soft, flex
and nonabrasive; the BC-CdHAP matrix can be packed against the sinus membranes and
cause damage.  If perforation does occur during the operation, the CdHAP particles are 
immobilized in the cellulose and would not migrate into the sinus cavity.   
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Chapter 7 
Future Studies: Preclinical Animal Testing 
  
 
Additional testing must be carried out before this product can be put to clinical use as a 
bone substitute.  These remaining evaluations are outlined in Table 7.1.  A research and 
develop
C-
r    
 In 
   
Table 7.1: Remaining steps towards bringing BC-CdHAP to clinical use 
 
 
* Does not include capital equipment needs 
** Assumes 20 patients at $15,000 each 
*** Includes growing, cleaining, and processing of raw material; product preparation, formulation, 
and packaging in controlled environment 
 
Item Cost Duration
Misc. Development* 10,000$     24 mo
Pr inical Efficacy - Large Mammal 80,000$    12 mo
Cy toxicity 1,500$       3 mo
Irr tion 1,000$       3 mo
Se sitization 7,000$       3 mo
Ac e Systemic Toxicity 750$          6 mo
Hemolysis 750$          3 mo
Genotoxicity / mutagenicity 23,000$     6 mo
Subchronic Toxicity 21,000$     6 mo
Chronic Toxicity 30,000$    9 mo
Sc e-up/Validation* 10,000$     6 mo
FDA Regulatory Fees - 510(k) 3,000$       4 mo
Cl ical Evaluation** 300,000$   18 mo
Misc. Consulting 24,000$     24 mo
Capital estimate*** 300,000$  24 mo
TOTAL 812,000$  
Pr
ec
lin
ic
al
 S
af
et
y
ment director from a medical products company was consulted to estimate the 
approximate cost and time to execute these tasks.   
Another crucial step before this composite can be used is obtaining FDA approval.  B
CdHAP is classified as a Class II device (FDA Section 872.3930) and would most likely qualify fo
the less rigorous 510(k) procedure as opposed to the substantial Premarket Approval process. 
the 510(k), it must be demonstrated that BC-CdHAP is composed of materials that are 
substantially equivalent to devices that have already been FDA-approved.
 
ecl
to
ita
n
ut
al
in
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Xylos® Corporation (Langhorne, P ained FDA approval for their bacterial 
mater and rotator cuff.  Xylos® was able to receive all their FDA approvals via the 510(k) process. 
these 
ch 
efore a biomaterial can be employed in clinical use, it must undergo rigorous evaluation 
nt of this evaluation  
is biological testing to prove that it is compatible and will function in a biologically appropriate 
manner in the clinical in-vivo environment [146I].  In-vitro testing with isolated mammalian cells 
gives some indication of a material’s biocompatibility, but it is important to determine the 
biological response in a fully integrated system.  A material which may show a positive in-vitro 
response may produce completely different results when implanted in a living organism.  Ratner 
offers the example of how most mammalian cells will attach and proliferate on surface-modified 
tissue culture polystyrene, but none will attach or grow on untreated polystyrene, however both 
materials react indistinguishably when implanted in-vivo and heal with a thin foreign body capsule 
[146].  In-vivo testing with animal models gives a much closer indication of how a material 
responds to all the chemical/biological species and physical stimuli present in a living organism.  
dard requirement in the development of medical 
A, U.S.A.) obt
cellulose wound dressing called XCell  as well as bacterial cellulose repair material for the dura ®
Since both bacterial cellulose and hydroxyapatite have been used in several FDA-
approved medical devices, it can be proved that BC-CdHAP is substantially equivalent to 
existing products.  It is anticipated that a 510(k) application can be approved without mu
difficulty.   
A logical next step in the development of BC-CdHAP is preclinical animal testing.  
Though not carried out, a protocol to evaluate the composite using a rabbit calvarial model was 
designed and will be described in this chapter. 
 
7.1.  Necessity of In-Vivo versus In-Vitro Testing 
B
with a variety of tests to ensure its safety and efficacy.  An integral compone
Preclinical testing in small mammals is a stan
devices and materials for human clinical use.  The FDA, ASTM, and USP all provide procedures, 
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protocol
7.2.  Se
rge 
f previous work in the literature that validates the use of rats in bone substitute testing, 
and the e 
pplications.  Direct feedback from the surgeons 
dicated that this material would find great success for site extraction preservation and sinus lift 
n of 
 
1 
pain or discomfort, is by definition a painful procedure.  A literature must be performed to find 
s, guidelines, and standards that may be used in the in-vivo assessment of the tissue 
compatibility of medical devices [147].   
 
lection of Animal and Bone Defect Model 
Pigs, dogs, rabbits, rats, and mice are accepted animal models for the in-vivo 
assessment of bone substitutes [147].  Rabbits are selected for this study since there is a la
presence o
y can be easily and economically obtained through reputable vendors.  Based on th
surgeon interviews reported in the last chapter, it was concluded that this particular bone graft 
would ideally be used in oral and maxillofacial a
in
procedures.   
The rabbit calvarial model is ideal for the assessment of bone grafts for the regeneration 
of craniofacial defects [148].  The calvarium has a low incidence of morbidity, has close proximity 
to the operative site, has a decreased amount of resorption as a result of its membranous nature, 
and does not require fixation due to the support provided by the dura and overlying skin.  The 
critical size defect in rabbit calvaria has well studied and extensively used in the evaluatio
potential bone grafts [149,150,151].  The results of these studies have shown the value of this 
model to evaluate the bioactivity and biocompatibility of bone graft materials.  The steps of this 
procedure, the necessary animal care, and the size of the defects required are well established. 
 
7.3.  Alternatives Search 
 The Institute for Animal Care and Use Committee (IACUC) and USDA mandate that 
alternative procedures must be considered for procedures involving all live vertebrate animals, 
which obviously cause more than momentary pain, distress, or discomfort. The USDA (Policy 1
& 12) states that any procedure, which requires the use of an anesthetic or analgesic to prevent 
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alternatives that can either replace animal methods with non-animal methods, reduce the numb
of animals needed, or refine research pro
er 
cedures to minimize pain and discomfort. 
A literature search was conducted using Medline / Pubmed, Web of Science, and 
droxyapatite and bone substitute,” “Calcium-
deficien and 
-
ite 
sis route.  The CdHAP in the bacterial cellulose (BC) matrix has a similar size (10-
50 nm) 
ere 
 
biomate reason, an animal study must be conducted to validate use of this potential 
is bone graft could be used to treat animals and humans alike. 
he 
 
Agricola.  Keywords used were “Calcium-deficient hy
t hydroxyapatite and in-vivo”, “Bacterial Cellulose,” “Bone substitute and rabbit 
calvarium,” “Rabbit and calvarium and critical size defect.”  
This literature search confirmed that there has been no biological testing done on this 
proposed bone graft consisting of calcium-deficient hydroxyapatite and bacterial cellulose (BC
CdHAP).  A study by Bourgeois et al. performed in-vivo testing on calcium-deficient hydroxyapt
(CdHAP) particles suspended in hydroxypropylmethylcellulose (plant derived) in a rabbit femur 
[37].  However, the CdHAP used in this study was a 40-80 μg powder made via a completely 
different synthe
and geometry to bone apatite and is chemically bonded to the BC matrix.  BC also has a 
similar nanofibril structure to natural collagen found in bone.  However, Bourgeois et al. did 
confirm that CdHAP was a biocompatible and bioactive substance that elicited new bone ingrowth 
[37].   
 As there has not been a preclinical animal study performed on this specific material, th
is not a sufficient replacement method for this important work.  As previously stated, in-vitro 
testing gives some indication of a material’s biocompatibility; but an integrated biological system
(e.g. animal model) is necessary to thoroughly assess the safety and efficacy of a clinical 
rial.  For this 
bone graft.  If successful, th
 
7.4.  Statistical Determination of Replicates 
 It is necessary to precisely calculate how many replicates will be required so that enough 
statistical data can be obtained while minimizing the number of animals that must be used.  The 
services of the University of Tennessee Statistical Consulting Center were used to determine t
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sample size necessary for a statistically strong study.   The results of a similar study was used to 
determine an approximate standard deviation.  JMP statistical software (SAS: Cary, NC, U.S.A.) 
as use ith a 
 
 nd 
ad 
d 
 was 
 
 
w d to determine the sample size necessary for detect a given difference in means w
given statistical power (Table 7.2).  The number of replicates vary depending on the amount of 
statistical power desired and the degree of sensitivity required to detect significant difference
between means.  
This would be a new study, which makes it difficult to anticipate the ranges of means a
standard deviations.  Previous studies were surveyed to determine what number of replicates h
previously been used for similar testing [149,150,151].  The number of replicates varied 
significantly from study to study, ranging from as many as twenty to as little as three [149,150].  
However, most studies used average of 4-6 replicates.  Other biostatistics references have cite
that four to six animals per study group is the minimum necessary for adequate statistical power 
to gain useful information using analysis of variance for repeated measures to assess any 
statistical differences within and between groups and times [152].  Based on these results, it
determined that six replicates would be sufficient for this study. 
 
7.5. Testing Protocols 
 To thoroughly analyze the bone regeneration potential of the proposed material, two
separate studies will be carried out.  Since different synthesis parameters of the material may 
 
Table 7.2: Statistical determination of replicates using JMP Software (SAS: Cary, NC, U.S.A.) 
 Number of Replicates for Number of Replicates for 
80% Statistical Power 90% Statistical Power 
To detect a 5% difference in bone 10 20 
ingrowth between groups 
To detect a 10% difference in 
bone in
5 6 
growth between groups 
To detect a 15% difference in 
bone ingrowth between groups 
3 4 
To detect a 20% difference in 
bone ingrowth between groups 
3 3 
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affect bone growth, the first test will be a screening study to determine what specific material 
formulation elicits the most bone growth.  The optimal material determined in the screening study 
will then undergo a second study where it will be implanted in a critical size defect. 
 
7.5.1.  Screening Study 
 The two main factors that will be tested are the use of native versus oxidized cellulose 
 
 
and varying the weight percentage of the calcium-deficient hydroxyapatite (CdHAP).  Native and 
oxidized cellulose will be tested with three 3 different weight percentages of CdHAP (15, 30, and 
50 wt%).  In all, nine conditions will be analyzed as described in Table 7.3. 
Since this will be a brief evaluative study, a smaller defect size (6 mm) and short test 
duration will be used (one month).  A New Zealand rabbit calvarium can accommodate four 6 mm
defects (Figure 7.1).   Fourteen rabbits will be used in all for the screening study providing 56  
 
Table 7.3: Sample conditions and abbreviations for first screening study 
Testing Condition Condition Abbreviation 
Empty defect Emp 
Native bacterial cellulose Nat 
Native bacterial cellulose with 15wt% CdHAP Nat15 
Native bacterial cellulose with 30wt% CdHAP Nat30 
Native bacterial cellulose with 50wt% CdHAP Nat50 
Oxidized bacterial cellulose Ox 
Oxidized bacterial cellulose with 15wt% CdHAP Ox15 
Oxidized bacterial cellulose with 30wt% CdHAP Ox30 
Oxidized bacterial cellulose with 50wt% CdHAP Ox50 
 
 
 
six millimeter defects [modified from reference IV] 
 
Figure 7.1:  Rabbit calvarium with four 
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defects.  To produce a statistically sufficient study, each of the 9 conditions will be expressed at 
After implantation, the implant site will be evaluated to determine the capacity of the 
bone.  The total bone volume in the defect will be determined using 
istolog
ne are administered 
to the a
 
A well- otential ) is the critical 
s  Schmitz and Hollinger [153].  A suc ul BRM will heal more 
q deal testing mo ld demonstrate defect 
h critical size defect (CSD) is the smallest 
i ation during the lifetime of the animal, and is 
s 3].  Testing p l BRMs in a CSD model 
provides conclusions as to whether a material possesses bone 
regeneration properties [153].   
 Based on the results of the screening study, the most successful composite formulation 
will be used in a full critical size defect study in rabbit calvaria.  Schmitz and Hollinger determined 
that the critical size defect for rabbit calvaria is 15mm [153].  A rabbit calvarium can 
accommodate two full 15 mm critical size defects (Figure 7.3).  For this study, one defect will be  
least six times with two conditions will be expressed seven times.  Each rabbit defect will been 
randomly allocated a sample to reduce statistical error as shown in Figure 7.2. 
composite to regenerate 
h ical staining with calcein green.  Additionally, bone ingrowth will be assessed using 
histomorphometry with tetracycline double labeling.  This technique calculates kinetic data on 
bone turnover.  Tetracycline binds to newly formed bone at the bone/osteoid (unmineralized 
bone) interface where it produces a linear fluorescence.  Doses of tetracycli
ctive site ten and three days prior to sacrifice.  The amount of bone formed between 
tetracycline injections can be calculated by measuring the distance between the two fluorescent 
labels. 
7.5.2.  Full Critical Size Defect Study 
 established model for testing p bone repair materials (BRM
ize defect as developed by cessf
uickly than a control (empty) defect [154].  An i del wou
ealing only in the presence of a BRM [154].  A 
ntraosseous wound that will not heal by bone form
pecific to the species and location of the bone [15 otentia
 affirmative and scientifically sound 
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 Figure 7.2: Random assignment of samples to rabbit calvarial defects for screening study 
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Figure 7.3:   Rabbit calvarium with two 15 millimeter full critical size defects [IV] 
 
filled with the composite material while the other defect will be left empty for comparison.  
Eighteen rabbits will be used in all over three months, with three one month timepoints taken.  
After each month, six rabbits will be sacrificed and evaluated for bone ingrowth using histology 
and histomorphometry as described in the screening study.  
 
7.5.3.  Description of Animal Procedures  
Specific Pathogen Free New Zealand White Rabbits will be purchased from Myrtle’s 
Rabbitry (Thompson Station, TN, U.S.A.).   Fourteen rabbits (6-7 lbs, male and female) will be 
acquired for the screening study and eighteen will be used for the critical size defect study.  
Rabbits will be tattooed for identification at the rabbitry prior to shipping.  The animals will be 
placed in appropriate shipping crates and a gel pack will be provided for each rabbit.  They will be 
flown into Tyson McGhee Airport where a courier service will pick them up and deliver them to 
animal facility. 
At the animal facility, rabbits will be housed in separate stainless steel cages where they 
will be provided with food and water by the animal facility staff.  The animals will have a one week 
acclimation period to recover from stress and environment change. 
Food and water intake will be restricted twelve hours prior to surgery.  Surgery will be 
ry, carried out under aseptic conditions in a dedicated surgical suite.  Half an hour before surge
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Buprenorphine (0.02 mg/kg IM), Atropine (0.1 mg/kg IM), and Ancef (3.5 mg/kg IM) will be 
administered to each animal. 
The animals will be anesthetized with Ketamine (3.5 mg/kg IM) and Xylazine (5 mg/kg 
IM).  Level of anesthesia will be constantly monitored by observing respiration rate, heart rate, 
corneal reflex, color of mucus membranes, and muscular relaxation.  The surgical site (calvarium) 
will be prepared by shaving and sterilization with betadine.  A 3-4 cm vertical incision will be 
made along the midline of the calvarium with blunt dissection down to the bone followed by 
osteum.  Four 6 mm diameter defects will be made using a standard bone 
 graft material 
ost-surgery, and then again as 
ed for pain.  Rabbits will be monitored post-operatively for anesthesia and surgical recovery 
serving color of mucus membranes, corneal reflex, 
muscle coo
gical and histomorphometric analysis, carcasses will be disposed by 
incinera
elevation of the peri
trephine: two on either side of the midline.  Sterile samples of the composite bone
will be placed into certain defects while other defects will remain empty for comparison. 
The periosteum will then be replaced over incision and sutured (3-0 Vicryl).  Fascia, 
subdermal, and skin layers will then also be closed by suturing (3-0 PDS and 3-0 Vicryl). 
Buprenorphine (0.02 mg/kg IM) will be administered immediately p
need
by measuring heart and respiration rate and ob
rdination, and return to normal eating habits and activity levels. 
Post-surgery, rabbits will be monitored at least twice daily by observation of respiration, 
eating habits, fecal output, and activity levels.  Animals will be weighed at the beginning of the 
study and once a week subsequently. 
On the tenth and third day prior to sacrifice, each animal will be administered an injection 
of tetracycline (10 mg/kg IM).  Animals will be euthanized by a lethal dose of Beuthanasia (1 
mg/kg IV).  After histolo
tion.   
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Appendix A.  List of Symbols and Abbreviations 
 
ATCC  American Type Culture Collectio  
BC  Bacterial Cellulose 
BC-CdHAP Bacterial Cellulose-Calcium Deficient Hydroxyapatite 
BCP  Biphasic Calcium Phosphate 
BMP-2  Bone Morphogenetic Protein - 2 
β-TCP  Beta Tricalcium Phosphate 
CaCl2  Calcium Chloride 
Ca(OH)2 Calcium Hydroxide 
Ca2SO4  Calcium Sulfate 
CdHAP  Calcium Deficient Hydroxyapatite 
DAC  Dialdehyde Cellulose 
DBM  Demineralized Bone Matrix 
DFDB  Demineralized Freeze-Dried Bone 
EDS  Energy Dispersive Spectroscopy  
FDA  Food and Drug Administration 
FTIR  Fourier Transform Infrared Spectroscopy 
FWHM  Full Width at Half Maximum 
G. hansenii Gluconacetobacter hansenii 
HAP  Hydroxyapatite 
HEPES  4-(2-Hydroxyethyl)-1-Pipe ulfonic Acid 
2SO4  Sulfuric Acid 
F  Insulin-like Growth Factor 
  Infrared 
2HPO4 Potassium Phosphate Dibasic 
Br  Potassium Bromide 
SC  Mesenchymal Stem Cell 
aOH  Sodium Hydroxide 
a2HPO4 Sodium Phosphate Dibasic 
a5P3O10 Sodium Tripolyphosphate 
CP  Octacalcium Phosphate 
DGF  Platelet Derived Growth Factor 
DF  Powder Diffraction File 
LIF  Posterior Lumbar Interbody Fusion 
LA  Polylactic Acid 
MMA  Polymethylmethacrylate 
HEMA Polyhydroxyethylmethacrylate 
BMP-2 Recombinant Human Bone Morphogenetic Protein - 2 
EM  Scanning Electron Microscopy 
HAP  Stoichiometric Hydroxyapatite 
EM  Transmission Electron Microscopy 
GF-β  Transforming Growth Factor Beta 
V  Ultraviolet 
V-Vis  Ultraviolet-Visible 
RD  X-Ray Diffraction 
n
 
razineethanes
H
IG
IR
K
K
M
N
N
N
O
P
P
P
P
P
P
rh
S
s
T
T
U
U
X
 
 
 
 
 
 
 
 
 120
Vita 
 
 121
ejo, CA on February 9, 1979.  She moved to Suffield, 
c ut at the age of 3; and then to Saratoga Springs, New York at the age of 4.  She went to 
 schoo y in Saratoga Springs NY, and then attendance of 
ng l.  She graduated from Saratoga Springs Senior High School 
f 1997
n for the Advancement of Science and Art in New 
it  on a fu ceived a Bachelor’s of Science degree in 
e ing with
ion in May 2001, Stacy moved to Knoxville 
e in Ja nt at Oak Ridge National 
rat y unde  Science and Engineering Higher Educational 
ces pro ical Sciences Division of Dr. Elias Greenbaum’s 
r Biosci roup under the tutelage Dr. Barbara Evans and Dr. 
ill. 
he University of Tennessee’s Graduate Program in 
p rtment e, and Biomedical Engineering.  She was awarded the 
nc aduate Research Fellowship in the summer of 2003.  Stacy 
her Ma ring Science in May 2004.  She is currently 
ng her Do gineering under the guidance of Dr. Roberto 
n t the U
 
 Stacy Hutchens was born in Vall
Conne tic
grammar l at Dorothy Nolan Elementar
Saratoga Spri s Junior High Schoo
in June o . 
 Stacy then went to The Cooper Unio
York C y ll tuition scholarship.  There she re
Engine r  a focus in Biomedical Engineering.   
 After graduating from The Cooper Un
Tennesse nuary 2002.  There she worked as a research assista
Labo or r the Oak Ridge Institute of
Experien gram.  She worked in the Chem
Molecula ence and Biotechnology G
Hugh O’Ne
 In August of 2002, she enrolled in T
the De a of Mechanical, Aerospac
National Scie e Foundation Gr
received ster of Science Degree in Enginee
pursui ctorate Degree in Biomedical En
Benso  a niversity of Tennessee. 
 
 
 
 
 
 
 
